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Extraintestinal pathogenic strains of Escherichia coli cause a wide range of diseases 
including colibacillosis in chickens and urinary tract infections in humans.  Persistent 
infections in E. coli and other gram-negative species are associated with population-
dependent physiological processes such as cell-cell signaling and biofilm formation.  
Such social behaviors require careful coordination and modulation of gene expression 
in response to environmental cues.  Adaptive response of bacteria in new 
environment is predominantly achieved through a signaling cascade called two-
component regulatory systems.  The function of the BarA/UvrY two-component 
regulatory system and its downstream factors in controlling virulence associated 
processes, specifically regulation of AI-2 based signaling and biofilm formation was 
investigated.    
 
  
In E. coli, a type of cell-cell signaling termed Quorum Sensing involves release, 
detection, and response to small molecule called autoinducer (AI-2), synthesis of 
which is dependent on luxS gene products via methyl cycle.  The BarA-UvrY and Csr 
system displayed dual regulation on luxS expression at the level of transcription and 
post-transcription.  The uptake of AI-2 by the Lsr transporter is also modulated by the 
signaling cascade suggested a balance between AI-2 synthesis and uptake in the cell.   
 
The role of transcriptional regulator uvrY in biofilm formation in Uropathogenic 
Escherichia coli was also studied.  Mutation of uvrY reduced expression of fimA and 
papA, major fimbrial subunit of Type 1 and Pap pilus respectively.  Acidic 
exopolysaccharide accumulation and the ability to swarm are also being impaired.  
Finally, uvrY mutants demonstrated poor colonization in kidneys and bladders in an 
ascending model of UTI.  Overall, the effect of uvrY on biofilm formation seems to 
be multi-factorial and might play a critical role in adaptation and colonization of 
UPEC.    
 
The fine tuning of processes associated with cell-cell communication and biofilm 
formation at the level of transcription and post-transcription by the BarA/UvrY/CsrA 
signaling cascade indicated that this system might be crucial for quick adaptation, 
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Chapter I: Background and Literature Review  
The ability to adapt under varying environmental conditions and colonize is an 
important determinant for perpetuation of bacterial species.  Adaptation of bacteria 
requires detection of the signal from the surroundings and appropriate responses that 
render fitness in a new setting.  The integration of diverse signals to appropriate 
response requires a flow of information from extracellular milieu to the interior of the 
cell.   In bacteria, two-component systems are the major signaling devices for 
detecting environmental cues and transducing it into the interior of the cell usually via 
a cascade of phosphorelay.   The responses of this signaling cascade enable bacterial 
adaptation, persistence and virulence of the bacterium by alteration of gene 
expression [1-4].   
 
Two-component systems respond by alteration of gene expression in diverse 
physiological processes including osmolarity, metabolism, nutrient acquisition, stress 
response, pH and expression of virulence factors [5-8].   These signaling systems are 
required for establishment and maintenance of the infection by a bacterial pathogen. 
The ability to cooperate and communicate in a community structure in the form of 
biofilm enables microbes to perform important cellular functions such as that of 
adaptation and persistence inside host.   Interactions among community members are 
crucial for temporal and coordinated response and are often mediated by a process of 
population-dependent cell-cell communication known as quorum sensing.  The 




virulence, has been demonstrated in a number of bacterial species including 
Streptococcus, Vibrio, Pseudomonas and Escherichia coli [9-11].  Here regulation of 
social behavior, particularly quorum sensing and biofilm, are explored in E. coli using 
a model two-component regulatory system.  
 
Escherichia coli as commensal and model pathogen 
Escherichia coli belong to a major facultative anaerobe commonly found in the 
intestinal tracts of homeothermic animals including man.  E. coli colonizes the 
gastrointestinal tract within few hours after birth.  In 1885, Theodor Escherich 
isolated the microbe from fecal flora of normal infants and later on documented them 
as important commensals in intestinal tract and pathogen in human intestinal and 
urinary tracts. E. coli displays a wide range of strain variation depending on the 
presence of certain antigens, typically O somatic lipopolysacchides, K capsular and H 
flagellar antigens [12].  Furthermore, array of adhesins having varying receptor 
specificity add to this strain diversity [13].  Extensive strain variation makes E. coli 
an ideal model for studying microbial adaptation and host-pathogen interaction [14, 
15].  E. coli K-12, a prototypic attenuated strain have been commonly used in the 
laboratory practices [16]. However, this strain lacks virulence factors such as fully 
functional O-antigen and ability to colonize mammalian intestine[17].  
 
E. coli strains are broadly classified in three groups: commensal strains, intestinal 
pathogenic (also referred as enteric or diarrheagenic) and extraintestinal pathogenic 




humans.  Typically, E. coli colonizes the gastrointestinal tract of human neonates 
within few hours after birth.  Commensal E. coli usually persist in mucous layer of 
the mammalian colon where they colonize and thrive making it one of the most 
abundant facultative anaerobe in the microflora. Commensals are usually beneficial to 
hosts but they can cause infections in compromised or immunologically challenged 
patients.  In contrast, intestinal and extraintestinal pathogenic species have additional 
virulence factors such as plasmids, bacteriophages and pathogenicity islands[18-20].  
Commonly used name for this group include enterotoxigenic E. coli (ETEC), 
enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), Shiga toxin-
producing E. coli or enterohemorrhagic E.coli (STEC or EHEC), enteroaggregative E. 
coli (EAEC), and diffusely adherent E. coli (DAEC).   The intestinal pathogenic 
groups are limited in their ability to cause infection only in the intestinal tract.  Each 
pathotypes within intestinal pathogenic strains have unique set of virulence traits 
resulting in a characteristic syndrome [21, 22].  Strains within each group show 
distinct phylogenetic relationship and diversity within each group are thought to be 
result of horizontal gene transfer.  Intestinal pathogenic E. coli are the leading cause 
of severe and infant diarrhea in developing countries and remain a major public 
health problem across the globe resulting two million deaths every year [23, 24].   
 
Extraintestinal Pathogenic Escherichia coli (ExPEC) 
Lately,  a third group termed as Extraintestinal pathogenic E. coli (ExPEC) has been 
formed based on the presence of specific virulence factors and ability to cause 




circulatory and respiratory system [25-27].  Strains which cause extraintestinal 
disease usually do not cause diarrheagenic disease and vice versa. However, ExPECs 
are capable of asymptomatically colonizing the intestinal tract in one-fifth of normal 
human population.   ExPECs are distinct both phylogentically and epidemiologically 
when compared to intestinal and pathogenic strains [28].   
 
ExPECs are increasingly a growing concern as evidenced by being causative agents 
of a plethora of diseases including urinary tract infections (UTI), neonatal meningitis, 
intra-abdominal infections, intra-vascular site infection, pneumonia, septicemia, 
osteomyelitis and other extraintestinal infections resulting huge economic impact on 
public health and society [29].  ExPECs are the most common gram-negative 
pathogens that cause extraintestinal infections under clinical settings.  
 
Increasing resistance to antimicrobial agents makes ExPEC associated infections 
complicated and difficult to treat [30].   Typically ExPEC characteristic virulence 
factors aid in invasion and colonization leading to infection in extra intestinal sites.  
Currently, ExPECs are found resistant to many of host’s defenses including resistance 
to bactericidal activity by neutrophils, cationic antimicrobial peptides and 
complement [31-34].   
 
Virulence factors associated with ExPECs 
ExPECs are phylogenetically, epidemiologically, genetically and clinically distinct 




ExPECs are larger and much varied than commensals probably due to acquirement of 
genes through horizontal transfer by mobile genetic elements such as transposons, 
phages, plasmids and pathogenicity islands (PAI) from diverse related or non related 
species [38, 39].  The acquired gene pool facilitates better adaptation and infection in 
extraintestinal sites as compared to commensals.    
 
Important ExPEC specific virulence factors include adhesins such as Type 1 fimbriae 
or P fimbriae, factors that evade defense mechanisms such as capsules, 
lipopolysaccharides, toxins including hemolysins, and factors to acquire nutrient 
availability such as siderophores [40].   ExPECs were defined as isolates of E. coli 
having at least two virulence markers from a list of papA, papC, sfa/foc, afa/dr, 
kpsMTII and iutA.  Other ExPEC associated virulence markers include papGIII, fimH, 
hly, K1, ireA etc.   Among the ExPECs, uropathogenic E. coli (UPEC) and avian 
pathogenic E. coli (APEC) cause significant morbidity and or mortality in humans 
and poultry respectively.   
 
Uropathogenic Escherichia coli (UPEC) 
UPEC is the leading cause of urinary tract infections in the United States. Every year 
in the United States alone, UPEC associated UTI results in 6-8 billion cases of 
uncomplicated cystitis with a healthcare cost of $1 billion, 250,000 cases of 
uncomplicated pyelonephritis with a direct cost of $175 million, and 250,000 to 




million dollar [30].  UPEC is one of the well characterized pathogen in UTI and often 
used as a model species for studying host-pathogen interaction [14].   
 
In contrast to commensal strains, UPEC possess large regions of DNA termed 
“Pathogenicity islands” (PAI) consisting of clustered genes encoding virulence 
associated factors [41-44].  The virulence attributes of UPEC include adhesins, 
toxins, lipopolysaccharides, capsule, proteases and iron acquisition systems [45-48].  
Adhesins are the key components mediating attachment with biotic and abiotic 
surfaces often marked with biofilm formation [49].  Biofilms formed on abiotic 
surfaces by UPEC such as that on the surfaces of medical implants and urinary 
catheters result in chronic recurrent infections presumably due to increasing antibiotic 
resistance.  Within hosts, adhesins initiate biofilm formation which plays an 
important role in protection from hosts innate immune responses and persistence of 
UPEC [50-52].   Several adhesins including outer membrane proteins, curli, and pili 
or fimbriae are important for mediating attachment [53, 54].  Among the pili, Type 1 
and Pap Pilus are critically important for pathogenesis of UPEC in the UTI [55-58].   
Other fimbriae such as F1C, M, S and Dr/Afa also contribute to colonization [47, 59-
61].  The pilus shows diversity in terms of structure and tissue specificity.  Type 1 
pilus is short and stubby whereas the Pap pilus is long and flexible [62].  Type 1 pilus 
is essential for mediating cystitis and shows tropism for mannose specific receptors 
on the bladder epithelium, Pap pilus, on the other hand, have predisposition towards 
digalactoside receptors on the kidney epithelium [55, 56, 63, 64].  Type 1 pilus have 




pap pilus is more predominantly expressed in pyelonephritic strains [65].  Flagellar 
motility may further promote ascension in the urinary tract [66, 67].  
Avian Pathogenic Escherichia coli (APEC) 
Avian Pathogenic Escherichia coli (APEC) is found in the intestinal microflora of 
healthy birds and usually affects chickens, turkeys, ducks and other avian species 
[68].  APEC is responsible for infections in extraintestinal sites, particularly to 
respiratory tract and systemic infections.  APEC is the leading cause of avian 
colibacillosis, a disease characterized by air sacculitis, pericarditis, peritonitis, 
salpingitis, polyserositis, septicemia, synovitis, osteomyelitis and yolk sac infection 
[69, 70].  Fecal contamination on egg surface often leads to yolk sac infection 
resulting death of embryo or within few weeks after hatching of eggs.   
 
On the other hand, in the US, cellulitis caused by APEC is the second leading cause 
of condemnation of broiler chickens and results in an estimated loss of $40 million 
every year.  Diseases caused by APEC are often a secondary outcome of 
environmental and host predisposing conditions.  Previous infections with viruses 
such as Newcastle Disease virus (NDV) or infectious bronchitis virus (IBV) and few 
other agents affecting respiratory tract increases the chance of occurrence of APEC 
infections, presumably due to loss of cilia in the epithelial layer.  Commonly APEC 
isolates belong to O1, O2 and O78 serogroups.  Like UPEC, APEC also posses 
certain pathogenicity islands encoding virulence genes such as pap and ireA [71, 72].  
However unlike UPEC, APEC harbors one or more plasmids associated with 




resistance [73, 74].   Such plasmids have been demonstrated to be lethal in embryos 
and have the ability to cause urinary tract infection in mice [75].   Other important 
virulence determinants of APEC include Type 1 fimbriae, curli, K1 capsule, hydrogen 
peroxide resistance, LPS, temperature sensitive hemmaglutinin and serum survival 
[76-80].   
 
Biofilms and colonization 
Historically, microorganisms have been categorized as planktonic or sessile cells. 
While planktonic cells are considered important for rapid propagation and moving 
into new territories, the sessile cells in contrast, are thought to be important for 
perseverance.  It is believed that in nature bacteria often remain associated in the form 
of a sessile community known as biofilms enabling a unicellular existence in a 
multicellular community.  Biofilms may be defined as surface-attached 
microorganisms enclosed in a matrix [81-83]. The self synthesized microbial matrix 
termed as extracellular polymeric substances (EPS) contains polysaccharides, 
proteins and nucleic acids [84].  In nature, EPS is highly hydrated allowing free flow 
of nutrients and metabolites mimicking primitive circulatory system. EPS serves as a 
guard against environmental changes, antibiotics and chemical agents and plays a 
crucial role for formation and maintenance of biofilm architecture [85].  The 
composition of extracellular matrix is varied among species. Both non-pathogenic 





Biofilms have a significant impact on human or animal health, environmental and 
industrial settings. Biofilms contribute up to 80% of chronic inflammatory diseases 
including urinary tract infections (UTI), cystic fibrosis, otitis media, colitis, 
conjunctivitis, endocarditis, peridontitis, and prostatitis [86, 88]. Presence of biofilms 
in indwelling medical devices (such as urinary catheters) and other devices in 
healthcare settings have often resulted in increase in nosocomial infections [89-92]. 
Biofilm associated microorganisms have been considered responsible for many yet, 
undiagnosed infections in humans.  Biofilms are highly resistant to antibiotics and 
immune responses which make them difficult for treatment [91, 93, 94].  Secreted 
catalase helps in preventing ingress of hydrogen peroxide, while the matrix prevents 
antibodies to enter inside biofilms. Even phagocytes have been demonstrated to be 
unsuccessful in removal of biofilms. Additionally, periodical shedding of individual 
bacteria from the biofilm into the surrounding tissues cause certain infections to recur 
[95].  Advantages of persistence in biofilms include protection from environmental 
stresses (such as chemicals, UV, antibiotics), prevention from dehydration, horizontal 
gene transfer, exchange of nutrients and ease of communication within the 
community [96].   
 
Biofilms could form on diverse environments including inorganic surfaces such as 
soil, minerals, and metals as well as on organic surfaces such as tissues.  In nature, 
mixed species of biofilms can be frequently observed, but single species of biofilms 
are also seen in medical and device associated infections.  Molecular genetics studies 




multi-step process, requires cellular communication and expression of genes in 
biofilm associated bacteria is quite different as compared to planktonic cells.  Studies 
have demonstrated that biofilms are typically formed in high shear environment in 
both natural and artificial systems.   
 
The multi-stages of biofilm formation include initiation by attachment to a substrate, 
maturation into a microcolony, maintenance of biofilm architecture and dissolution. 
The process of initiation seems to be triggered by environmental signals such as 
nutrient availability [97].  Bacterial adhesion is facilitated by several adhesins and 
proteinaceous appendages that facilitate attachment by binding to cell surface 
receptors [51, 98].  This step is a crucial step for both native and pathogenic species 
for colonization.  Typically repulsion between bacterial and tissue cell surface 
prevents attachment and hence, hairy appendages, termed fimbriae or pili are usually 
located at the distal end of the bacterial surface to facilitate adhesion. The term “Pili” 
and “Fimbria” refers to non-flagellar bacterial filaments, have been often used 
interchangeably even though they have different connotation.  “Pili” is often used for 
transmission of genetic material during conjugation whereas “Fimbria” is more 
commonly used for appendages of attachment.  Pili are proteinaceous appendages 
having a thickness of 2-7nm in width and extending from 0.2 to 20μm outward from 
the bacterial surface.  The formation of pili involves helical assembly of multiple 
subunits of pilin protein which constitute the thick long proximal shaft.  The thin 
distal part encodes a tip adhesin protein promoting attachment to various surfaces 




shaft is presumed to distance the adhesin from the bacterial surface to facilitate the 
adhesion [99, 100].   
 
 Among the pili, Type 1 pilus is commonly present in almost all species and isolates 
of Enterobacteriaceae including the Uropathogenic E. coli (UPEC) and considered as 
a virulence factor in ascending model of UTI [101]. The biogenesis of the Type 1 
pilus takes place by a conserved chaperone usher pathway which is involved in 
assembly of thirty other adhesive organelles in gram negative species including the P-
type fimbriae.   In this pathway, the assembly of the fimbriae relies on a periplasmic 
chaperone, and an outer membrane usher. The chaperone helps stabilizing and folding 
of fimbrial subunits and a lack of it leads to aggregation of the subunits and 
subsequent degradation by the protease. The usher facilitates the assimilation of 
fimbrial subunits into the growing pilus shaft [102, 103].   
 
In E. coli, Type 1 pilus and flagellar motility is necessary for biofilm maturation [49, 
104].  Type 1 pilus is encoded by fim (fimA-fimH) gene cluster consisting of eleven 
genes including fimA, encoding the major pilus subunit, fimC encoding periplasmic 
chaperone, fimD encoding outer membrane usher and fimH encoding the tip adhesin.  
In E. coli variants of FimH have been detected which prefers a particular sugar 
moiety on cell surface over others for adhesion; for e.g., Fim H variants in 
commensal isolates of E. coli preferentially binds  to mono-mannose residues 
whereas pathogenic species including uropathogenic ones attach with higher affinity 




mediates internalization in bladder cells, leading to persistence and chronic urinary 
tract infections.  Type 1 pilus facilitates attachment and subsequent colonization by 
binding to mannose containing receptors on the eukaryotic cell surface [61].  Both 
Type 1 and P pilus has been used successfully as a vaccine candidate [101, 106, 107].   
 
Cell-cell communication 
Another aspect of cooperative behavior in bacteria is demonstrated very well in a 
recently investigated physiological process dubbed as “Quorum Sensing”[108].  
Quorum Sensing (QS) refers to the ability of bacteria to coordinate activities in a 
population-dependent manner by utilization of small molecules termed autoinducers 
[109-112].  The accumulation of autoinducers in the external environment increases 
with cell density and on achieving a critical threshold concentration, signaling 
transduction cascade activation leads to alteration in gene expression.  Such induced 
or repression of genes could include virulence, antibiotic production, motility, 
metabolism, chemotaxis, and biofilm formation [113-117].  Coordination of bacterial 
gene expression is thought to be crucial for a protection of bacterial community from 
immune responses as well as successful colonization in the new or harsh environment 
inside host.    
 
The phenomenon of Quorum sensing was originally identified in Vibrio fisheri [118, 
119].  The initial observation was the ability of the bacteria to produce light only at 
high-cell density led to the characterization of autoinducer, N-acyl homoserine 




gained considerable interest in which the bacteria thrive in nutrient-rich light organs 
of marine animals and produce light in a population-dependent manner.  The animals, 
in turn, use the light as a predatory device avoiding being preyed or catch a prey.  The 
phenomenon of bioluminescence has been observed only in symbiotic state of the 
bacteria even though the bacteria are able to exist between free living and in 
symbiotic association with the host.  In the free-living state, the autoinducer diffuse 
into the environment and the signal gets lost in the surroundings, whereas in a 
confined environment of the light organ of the squid the signal accumulates and flows 
back into the cell.  Light production in V. fisheri takes place in a population 
dependent manner through regulation of luxCDABE operon which encodes luciferase 
enzyme complex.  Two regulatory proteins are involved in this circuit.  LuxI protein, 
the autoinducer synthase synthesize the autoinducer molecule, acylated homoserine 
lactone (HSL), accumulation of which in extracellular environment increases directly 
with cell density.  Upon entering inside the cell, the autoinducer gets bound and 
activates LuxR, a response regulator. The activated response regulator, LuxR in turn 
binds to “lux” box a sequence to the upstream of the QS regulatory genes, recruits 
RNA polymerase and activates luciferase operon inducing bioluminescence [120, 
121].   Additionally, mutations in lux genes in Vibrio fischeri reduce the ability to 
colonize and persist in the hosts [122].  A transcriptional regulator, GacA  is also  
required for symbiotic association between the bacteria and the host [5].  
 
In contrast, Vibrio harveyi utilizes two signaling molecules, termed as AI-1, and AI-2 




sensor kinases which autophosphorylates at low cell densities and phosphate is 
sequentially relayed to LuxO, a transcriptional regulator via LuxU, a 
Phosphotransferase protein.  Phosphorylated LuxO, in turn, activates transcription of 
small RNAs (sRNA) which in association with Hfq destabilize the transcript 
encoding the LuxRVH, a transcriptional regulator. This results in repression of 
luciferase operon and no light production. At high cell densities, kinase change to 
phosphates and the flow of phosphates reverses, resulting in dephosphorylation of 
LuxO and collapse of small RNA synthesis and enhanced transcription of LuxR,  
which in turn  increases light production [123].   
 
Quorum sensing plays a key role in both the early and later stages of biofilm 
development.  Autoinducer such as acylated homoserine lactones (AHL), which 
senses bacterial cell density, frequently plays a role in microcolony formation 
whereas cross-species bacterial communication signal Autoinducer 2 (AI-2) 
influences thickness and biomass. This mode of communication is particularly  
important as biofilms in nature are often present in a group of mixed species. Thus, 
agents targeting such steps in community signaling could be an important step in 
controlling biofilm related infections [93, 124-126].  
Interestingly, the social behavior of quorum sensing and biofilm formation seems to 
be interdependent [9, 127].  While QS may be a key contributor of biofilm formation, 
high cell densities during biofilm development may be crucial in achieving “quorum”.   
Inhibition of Quorum Sensing offers a novel strategy for controlling biofilm related 
infections because of reduced risk of developing antibiotic resistance [128].  These 




and are crucial for efficient adaptation of the bacteria.  Environmental adaptation in 




Bacteria live in an environment where conditions change frequently.  Such conditions 
include a wide range of environmental cues such as change in pH, oxygen deficiency, 
temperature fluctuations, nutrient limitation, chemical signals.  Survival of microbes 
in any environment relies on adaptive responses that enhance persistence during 
unfavorable conditions.  Adaptive behaviors such as the ability to carefully utilize 
energy sources like carbon and nitrogen, a capacity to establish communication 
among members and resist toxic effects of the metabolic processes are critical for 
persistence of microbes.  Adaptive responses necessitate monitoring and detection of 
environmental signals, transduction of that information within the cell and elucidation 
of appropriate responses usually by alteration of gene expression.  The response could 
take place at the level of transcription or translation initiation.  
 
Adaptation of bacteria to new environment in bacteria is largely mediated by a 
sophisticated signaling system termed as the “Two-Component System” (TCS).  Two 
component systems are wide spread signal transduction devices that enable bacteria 
to detect, respond and adapt to environmental stimuli mostly through changes in gene 
expression [1].  More than four thousand TCSs have been detected in 145 completed 




fungi, yeasts, protozoa and in plants but not in C. elegans, Drosophila, mouse and 
human. The number of TCSs in bacteria seems to be directly correlated with 
increasing genome size and range of adaptation needed to persist in varying 
environments.   
 
A prototypic two-component system consists of a membrane-located sensor histidine 
kinase (HK) and a cognate response regulator (RR).   Upon reception of the 
environmental signal/s, the sensor kinase transduces the information to the response 
regulator via a cascade of phospho-transfer reactions.  The activated regulator then 
elucidates appropriate responses to make the organism acclimatize in the new 
environment usually involving gene regulation expression at the level of 
transcription. Direct interactions of response regulators with proteins were also 
reported [2, 129].   
 
Initial studies have demonstrated that two proteins EnvZ, a membrane protein and 
OmpR, a cytoplasmic regulator control outer membrane protein genes ompF and 
ompC in response to osmolarity changes in the environment.   This study 
demonstrated that information must be transmitted inside the cell via a membrane 
protein which must be able to sense environmental cues [130-132].  It was found that 
there are conserved amino acid sequences of OmpR and EnvZ in a set of E. coli 
proteins that responds to environmental cues which are then divided into two groups, 
one group having a conserved sequence of 240 amino acids while the other group 




demonstrated unique ability to undergo autophosphorylaylation at a conserved 
histidine residue and referred as “transmitters”, whereas the later group can receive a 
phosphate group at a conserved aspartate residue from the former group and called 
“receivers” [134-137].  Appropriately, the transmitter and receiver group of proteins 
are subsequently referred as “sensor histidine kinase (HK)” and “response regulators 
(RR)” and together they constitute “two-component regulatory system” which are 
environmental detection devices facilitating adaptation in a new environment by 
altering modulate gene expression [1, 138].  Interestingly, few systems employ an 
additional histidine domain called “phosphotransfer domain (Hpt)” which serves as 
an intermediate during transfer of phosphoryl from or to aspartate residue in RR.  
Since then, several such systems have been detected in numerous bacterial species, 
indicating the importance of such regulatory systems [139-143].  
 
Bacterial pathogens produce virulence factors such as adherence factors, capsules, 
enzymes, and toxins in order to overcome the host’s defense and cause successful 
colonization.  Virulence factors are expressed temporally through various stages of 
infection and carefully controlled.  Many pathogenic bacteria require motility for a 
successful colonization either in initial phase and/or for maintenance of infection.  
Successful colonization of a pathogen also needs coordination among members of 
community to express virulence in a population-dependent manner utilizing Quorum 
Sensing.   The importance of TCS in regulation of virulence has become apparent 
over the years as several TCS are implicated in physiological processes associated 




communication and bacterial adaptation inside host [5, 8, 144-146].  These processes 
are carefully synchronized for initiation, persistence and adaptation of bacteria inside 
the host.  However, on a cautious note, the phenotypes associated with attenuation of 
virulence could be due to interference with metabolic requirements of the cell.   Some 
examples are listed in Table 1.  One such two-component system, the BarA-UvrY 
TCS in Escherichia coli regulates diverse physiological processes including oxidative 
stress, sigmaS expression, biofilm formation, carbon metabolism and virulence.  
 
 
Figure 1.  Schematic of two-component regulatory systems. The arrows indicate the 
direction of phosphorelay. The classical sensor transfers the phosphate group from the 
histidine residue to the aspartate residue of the response regulator. The unorthodox 
sensor kinases have additional receiver and histidinephosphotransfer domain.  The 
























Table 1.  Virulence phenotypes associated with two-component regulatory system in 




Organism                            TCS                    Phenotypes                       
 
 
Salmonella enterica            PhoP-PhoQ         LPS modification [147]                                                           
 BarA-SirA TTSS, Invasion [148, 149] 
Bordatella Pertusis             BvgA-BvgS Toxin [150]  
Vibrio cholerae       ArcA-ArcB VF toxT [151] 
       VarS-VarA         VF hapR [152] 
 
Vibrio fischeri           GacS-GacA    Bioluminescence [5] 
Shigella flexneri       OmpR-EnvZ       Invasion [153] 
Pseudomonas aeruginosa   GacS-GacA AHL, biofilm [154]    
       RocA1-RocS1    Fimbriae, Biofilm [155] 
 
Neisseria gonorrhea PilA-PilB Pili synthesis [156] 
 
Helicobacter pylori             FlgR-FlgS           Flagella  [157]  
 
Staphlylococcus aureus      AgrA-AgrC Regulatory RNA III [158] 
 
Erwinia cartovora              ExpS-ExpA Enzymes [159] 
Serratia marcescens      PigW-PigQ Prodiogsin [160] 
Legionella pneumophilles   LetS-LetA Cytotoxicity [161] 












Adaptation of E. coli to new milieu requires several two-component systems which 
plays a crucial role for survival in a dynamically fluctuating environment.  
Sequencing of the entire Escherichia  coli genome have aided in determining 29 
Histidine Kinase and 32 Response Regulator genes [163].  The BarA-UvrY TCS in 
Escherichia coli is pleiotropic and have been linked with several physiological 
processes including biofilm formation, oxidative stress, sigmaS expression, and 
efficient adaptation in carbon utilization [162, 164, 165].  The barA and uvrY gene is 
located at 62 and 42 minutes of the Escherichia coli chromosome, unlike many two-
component pair which are located next to one another.  The BarA-UvrY two-
component system and its orthologues are highly conserved in γ-division of 
proteobacteria.  Orthologues of this system in Pseudomonas (GacS-GacA), 
Salmonella (BarA-SirA), Erwinia (ExpA-ExpS) and Vibrio (VarS-VarA) have been 
shown to be strongly associated with virulence of the respective bacteria (Table 1).  
 
BarA - The Sensor Kinase  
The barA (bacterial adaptive response) gene (also called airS) encodes a 102kD 
membrane associated protein having both the sensor kinase and the response 
regulatory domains. Out of 29HK detected so far, only 5 sensor kinases are hybrid 
sensor kinases including BarA, ArcB, EvgS, RcsC and TorS.  BarA is a member of 
“tripartite” or “hybrid” kinases in E. coli with characteristic three domains:  a regular 




with a conserved aspartate residue (D1) and C terminal Phosphotransfer domain 
(HPt).  The Phosphorelay in this TCS is presumed to act in His-Asp-His-Asp fashion 
from the Sensor kinase to the Response Regulator.  Such multistep phosphorelay 
might offer reversible flow of phosphoryl group providing tighter control or 
incorporate various signals at an intermediary step or facilitate cross talk between two 
or more signaling cascades.  
 
BarA has been initially identified to phenotypically suppress the effect of a deletion 
mutation of envZ gene, which has been shown to regulate expression of outer 
membrane proteins with OmpR [166].  GacS of Psedomonas syringae pv. syringae, 
orthlogue of BarA, contributes to lesion formation in plants [167, 168] while  BvgS in 
Bordatella spp. regulates siderophore production [169].  Environmental signals to 
which BarA responds remain unclear, however the system seems to be activated upon 
reaching an optimal pH [170].  In Salmonella, intestinal short chain fatty acids have 
an effect on the virulence of BarA/SirA TCS [171].  Attachment of P-pilus to human 
red blood cells induces transcription of barA in UPEC which in turn upregulates the 
expression of iron acquisition system [172].  
 
BarA plays a role in bacterial adaptive response, particularly in regulation of 
oxidative stress response by enhancing catalase production through transcriptional 
activation of the rpoS gene [173, 174].  RpoS, the alternative sigma factor of E. coli, 
is also involved in regulating gene expression in response to pH changes and changes 




is one of the transcriptional regulators of rpoS.  It is yet to be seen whether this 
process is interdependent or not.   A domain analysis was performed to further 
understand the potential role of the kinase.  
 
Domain Analysis of BarA 
A domain analysis of BarA was performed using Simple Modular Architecture 
Research Tool (SMART) 
 





                           HisKA 292-357   
                                               HATPase_c 404-519 
                                                                            Response_reg 668-789 
                                                                                                           Hpt 828-912 
 
SMART analysis of BarA shows 5 domains: 
1. HAMP – This domain is known as the HAMP domain for histidine kinases, 
adenlyl cyclases, methyl binding proteins and phosphatases. Commonly found in 
bacterial sensor and chemotaxis proteins as well as in eukaryotic Histidine 
kinases.  The bacterial proteins are usually integral membrane proteins and part of 





2. HisKA –. The Histidine kinase A (phosphoacceptor) N-terminal domain is a 
dimerisation and phosphoacceptor domain of histidine kinases. It has been found 
in bacterial sensor protein/Histidine kinases. 
 
3. HTPase C – This family includes several ATP binding proteins – Histidine 
kinase, DNA gyrase B, topoisomerases, heat shock protein HSP90, phytochrome-
like ATPases and DNA mismatch repair proteins. 
 
4. REC – CheY homologous receiver domain regulates the clockwise rotation of E. 
coli flagellar motors. This domain contains a phosphoacceptor site that is 
phosphorylated by histidine kinase homologues. 
 
5. HPT – The Histidine Phosphotransferase domain contains active Histidine 
residues that mediate phosphotransfer reactions. This domain is detected only in 
eubacteria. 
 
UvrY - The Response Regulator 
UvrY, a 218 amino acid protein belongs to FixJ protein family was identified as the 
cognate response regulator of BarA in E. coli [176].  It has an N-terminal 
phosphoacceptor domain with a conserved aspartic acid residue at position 54 
followed by a LuxR type helix-turn-helix DNA binding domain in the C-terminal 




mRNA with uvrC, which is involved in DNA repair, but uvrY seems to have little or 
no role in UV-induced DNA damage repair [177].   
 
Mutation in uvrY leads to a hydrogen peroxide sensitive phenotype due to reduced 
expression of catalase in E. coli.   UvrY also have a role in biofilm formation.  
Interestingly, UvrY is critcal for switching between glycolysis and gluconeogenesis 
pathway for efficient adaptation which is presumably important for infection.  In 
Salmonella, SirA regulates virulence and directly binds to genes for hilA, hilC and 
csrB promoters [178, 179]. Mutation of gacA, in Pseudomonas and varA in Vibrio 
demonstrated reduced levels of autoiducers, defective in social behavior and 
virulence attributes in animal models [152, 180-183].  Salmonella ortholog sirA have 
been demonstrated to be activated by cya/crp regulation [184].  In Pseudomonas and 
Erwinia species uvrY othrologue, gacA controls quorum sensing, secondary 
metabolism and phytopathogenesis.  Increased expression of sdiA, which encodes a 
LuxR protein and involved in cell division, led to a significant increase in uvrY 
transcription.   In Photorhabdus luminescens, UvrY have been shown to regulate 
several virulence associated traits including quorum sensing, motility, 
bioluminescence and oxidative stress [165].  UvrY and its orthologues in control the 
expression of small RNA that is predicted to be present in γ-proteobacteria [180, 




Domain Analysis of UvrY 
Figure 3.   Domain organization of UvrY. 
 
 [218 residues]
   Response_reg 2-123 
            GerE 147-204 
 SMART analysis indicated two important domains of the Response Regulator UvrY: 
 
1. REC – CheY homologous receiver domain regulates the clockwise rotation of E. 
coli flagellar motors. This domain contains a phosphoacceptor site that is 
phosphorylated by Histidine kinase homologues. 
 
2. HTH LuxR – The lux regulon which activates the bioluminescence operon. They 
are a class of regulators which when bound to autoinducer “(AHL) gets activated. 
The Helix turn helix DNA binding domain of these proteins is located in the C- 
terminal section of the sequence. The many bacterial transcription regulation 
proteins which bind DNA through a 'helix-turn-helix' motif can be classified into 
subfamilies on the basis of sequence similarities. One of these subfamilies which 
includes proteins with sizes ranging from 74 (gerE) to 901 amino acids (malT), 
can be further subdivided into two classes on the basis of the mechanism by 
which they are activated. The first is a class of regulators which belong to a two-




phosphorylation, generally on an aspartate residue, by a transmembrane kinase. 
The members belong to this class include bvgA, comA, dctR; degU, evgA, fimZ, 
fixJ, gacA, glpR, narL, narP, nodW, rcsB and uhpA. The second is a class of 
regulators which is activated when bound to autoinducer molecules such as N-(3-
oxohexanoyl)-L-homoserine lactone (OHHL). Members belong to this class are 
carR, echR, esaR, expR, lasR, luxR, phzR, rhlR, traR and yenR. The 'helix-turn-
helix' DNA-binding motif of these proteins is located in the C-terminal section of 
the sequence. 
 
Integration of the BarA/UvrY/Csr System 
Recently there are increasing numbers of studies demonstrating importance of post-
transcriptional regulation by small noncoding RNA in adaptation and virulence [186]. 
Apart from transcription control, translation initiation is important for efficient 
adaptation and expression of virulence of  bacteria [187].   
 
Presently, two classes of small RNA are known to influence the rate of translation 
initiation by different mechanisms [188].  The first class of small RNA’s act by base 
pairing at the 5’end of the transcript, which could either stimulate or interfere with 
ribosome loading of various target mRNA.  Hfq, the RNA chaperone facilitates the 







On the other hand, another group of small RNA displays high affinity for a RNA-
binding protein, which control translational initiation and message stability of the 
transcripts.  The RNA binding protein is designated as CsrA or RsmA in various 
gram-negative bacterial species.  The acronym Csr stands for carbon storage regulator 
in E. coli, Salmonella and Vibrio species and Rsm for regulator of secondary 
metabolism in Pseudomonas and Erwinia species.    
 
Part of the downstream effect of the BarA-UvrY TCS in E. coli is mediated via 
Carbon Storage Regulatory system (Csr).  In this circuit, UvrY enhances transcription 
of two noncoding RNA’s called CsrB and CsrC.  These small RNAs in turn bind and 
titrates the activity of global RNA binding protein, CsrA [190, 191].  In an auto-
regulatory loop, CsrA also regulates this TCS and controls its own expression (Figure 
4) [192].  The control of CsrA could be both positive and negative for various target 
transcripts. CsrA could interfere with translation of target mRNA by binding at or 
near shine-dalgarno sequences thus occluding ribosome loading while accelerating 
message decay.  On the other hand, CsrA could also stabilize and increase translation 
of target mRNA.  CsrB and CsrC RNA’s contain several imperfect sequences that 
serve as multiple binding sites (upto 22 in CsrB) for CsrA protein. An important 
feature of these putative binding sites for CsrA is presence of a conserved GGA 
sequence in the stem loop regions of various target RNA’s.  Few direct regulatory 
interaction of CsrA have been recognized,  glg operon which encodes genes in 




involved in biofilm formation,  cstA that encodes a peptide transporter and hfq, that 
assists base pairing of transcripts [193-196].    
 
CsrA was initially identified as global regulator of glycogen biosynthesis, where a 
transposon mutagenesis in csrA increased accumulation of glycogen as compared to 
the parent strain [197].  Since then, CsrA homologues are detected in more than 
hundred species including proteobacteria, even some species having more than one 
CsrA homologue.  Structural studies indicated that CsrA acts as a dimer consisting of 
five β strands and one α helix per monomer.  The binding of CsrA with CsrB and 
CsrC is coopertaive.  CsrA plays a major role in central carbon metabolism, motility 
and biofilm formation in E.coli [192, 198, 199].  The BarA-UvrY TCS balances the 
carbon flux and switches between metabolic pathways by the use of the Csr system in 




Figure 4.    Schematic representation of the BarA/UvrY/Csr System.   
BarA, the hybrid sensor kinase undergoes autophosphorylation upon reception of signal 
in an ATP-dependent manner and phosphate is subsequently relayed to a conserved 
aspartate residue in the response regulator, UvrY presumably via His→Asp→His→Asp 
phosphorelay cascade.  UvrY also upregulate the expression of small non coding 
RNAs, CsrB and CsrC which in turn, titrates the activity of the global regulatory 
protein, CsrA by binding to it.  CsrA also regulates BarA/UvrY TCS in an 
autoregulatory feedback loop.  Part of the effect of the BarA/UvrY TCS is direct 



























Significance, rationale and approach of the study 
The major objective of this work is to further understand the role of the BarA-UvrY 
signaling cascade in adaptation and virulence. Adaptation of bacteria in a new 
environment requires careful coordination among members of a community.  Such 
synchronized behaviors in microorganisms are carefully controlled in response to 
multiple environmental cues. Two aspect of such social behavior are studied here: 
 
a) Population dependent gene regulation termed Quorum Sensing  
b) Complex community structure interaction through the formation of Biofilms 
Objective 1:    To determine the role of the BarA-UvrY two-component system in 
regulation of quorum sensing in E. coli  
Bacteria employ cell-cell communication to assess environmental cues and adapt 
accordingly to different niches for attachment and colonization.  Population 
dependent adaptation or quorum sensing in gram-negative bacterial species employs 
three kinds of signaling molecules.  These small signaling molecules are acyl 
homoserine lactone (AHL) called autoinducer-1 (AI-1) and a furanone called 
autoinducer-2 (AI-2) and AI-3.  The production of AI-2 is dependent on the luxS gene 
encoding the AI-2 synthase. Importantly A1-2 is synthesized as a by product of 
activated methyl cycle. In. E. coli S-adenosyl Methionine (SAM), a methyl donor to 
DNA, RNA and proteins donates methyl group to various substrates generating S-
adenosyl homocysteine (SAH). SAH is broken down to homocysteine by two gene 
products, pfs and luxS. Pfs, a nucleosidase, breaks down SAH into S-ribosyl 




generating homocysteine which goes back to the cycle. One of the by product of this 
last reaction catalyzed by LuxS is a compound called DPD (4, 5-
dihydroxypentanedione) which spontaneously undergoes cyclization and forms AI-2 
(Figure 5).  Both SAH and SRH are toxic to the cell and thus both Pfs and LuxS play 
a role in detoxification.  E. coli is not known to produce AI-1 as it does not have the 
AI-1 synthase. It has been suggested that AI-2 may represent a universal signal 
molecule, used for intra- as well as interspecies communication.  
Figure 5.  A1-2 is formed as a by product of activated methyl cycle. LuxS converts 
S-ribosyl homocysteine to homocysteine generating AI-2 as a by product. In 
eukaryotes, an enzyme termed SAH hydrolase converts S-adenosyl homocysteine to 




















The role of BarA-UvrY and its downstream regulators in luxS based quorum sensing 
was demonstrtated by using a single copy chromosomal luxS::lacZ transcriptional 
fusion.  The corresponding AI-2 levels were measured using a modified Vibrio 
harveyi reporter.  The involvement of CsrA was shown by transcript stability assay 
following addition of rifampicin, computational prediction of putative binding sites of 
luxS transcripts and direct regulatory interaction of CsrA with luxS transcripts.  
Furthermore, the regulation of lsr transport was assessed by reporter activity and real 
time RT-PCR.  The involvelemt of hfq and crp-cAMP was also assessed. This work is 
detailed in Chapter 3.  
 
Objective 2:  To identify candidate genes involved in biofilm formation by the BarA-
UvrY two-component system in Uropathogenic Escherichia coli.  
Uropathogenic Escherichia coli (UPEC) are the leading cause of Urinary tract 
infections in US resulting loss of productivity and financial burden on society.  UPEC 
is also the leading cause of nosocomial infections due to formation of biofilms on the 
abiotic catheter surfaces.  The virulence of UPEC depends on several surface 
structures which facilitates adhesion and biofilm formation eventually leading to 
persistent infections in the urinary tract.   Two adhesins, Type 1 pilus and Pap Pilus 
are crucial for efficient colonization in the urinary bladder and kidneys respectively.  
Other factors, such as extracellular polymeric substances and flagellar motility play 
an important role in biofilm formation and virulence.  Part of the downstream effect 





The role of the BarA-UvrY TCS in UPEC biofilm formation was initially tested on 
abiotic surfaces (Polystyrene and PVC surface).  Both Type 1 and Pap pilus 
expression was monitored in uvrY and csrA mutant to identify potential downstream 
regulation.  Transcript stability assy after addition of rifampicin was performed to 
ascertain potential role of CsrA.  Type 1 pilus undergoes phase variation and switches 
between ON (fimbriated) and OFF (afimbriated) phase.  The role of uvrY in Type 1 
phase inversion was determined by an inverse PCR method.  Potential role in acidic 
exopolysachharide accumulation was measured by Ruthenium Red staining.  The 
ability to swarm in soft agar was further tested.  Finally, mutants were tested for an 
ability to colonize in the bladder, kidneys and urinary tract in an ascending model of 
UTI in mice.  This work is summarized in Chapter 4. 
 
Objective 3:  To identify novel candidates affected by the BarA-UvrY genes in 
Uropathogenic Escherichia coli that can be employed for detection of toxicity.   
UPEC genome has unique 1600 Open Reading Frames whch are not found in 
commensals.  Adaptive stress responses in Escherichia coli are largely mediated by 
several two-component systems.   Bacterial biosensors have utilized stress response 
for detection of toxicity.  The BarA-UvrY TCS is pleiotropic and regulates diverse 
physiological processes including stress response through, stationery phase sigma 
factor, rpoS .   Transcription profiling of the TCS was performed to identify potential 
other genes that might be utilized as toxicity sensors.   The potential of this two-





Finally, work from Chapter 4 has contributed to a study where we showed mutation 
of the BarA-UvrY TCS in Avian Pathogenic Escherichia coli displayed reduced 
virulence in chicken embryo model and poor attachement in chicken fibroblasts and 
macrophage.   Mutation in BarA/UvrY TCS also demonstrated a reduction in 
mannose resistant haemmagluttination (Table 3). Downregulation of both Type 1 and 
Pap pilus, reduced exopolysaccharide production, and increased susceptibility to 





Chapter III:  Regulation of AI-2 based signaling by the 
BarA/UvrY/Csr system in Escherichia coli  
 
Abstract 
In Escherichia coli the BarA/UvrY/Csr system works in concert affecting 
physiological processes including carbon metabolism, biofilm formation and motility.  
Here, we report that the signaling pathway regulates luxS dependent AI-2 signaling 
system by evaluating a single copy transcriptional luxS::lacZ reporter expression, 
transcript levels and direct regulatory interactions.  The BarA/UvrY and Csr system 
displayed opposite regulation on luxS, the enzyme involved in synthesis of AI-2, 
indicated a potential dual regulation at the level of transcription and post-
transcription.  The uptake of AI-2 by the lsr (luxS regulated) transporter is also 
modulated by the signaling cascade suggested a possible dynamics of AI-2 synthesis 
and uptake in the cell.   
 
Introduction 
Alteration of gene expression in bacteria is critical for survival and persistence in a 
changing environment.  Perception of signal and appropriate response is 
indispensable for the fitness of bacterial species.  Two-component regulatory systems 
in bacteria are signaling cascades critical for adaptation in a new milieu and regulate 
gene expression usually at the level of transcription [1, 2].  A two-component system 
consists of a membrane-bound sensor histidine kinase and a cytoplasmic reposne 




orthologues of this TCS were detected in other γ proteobacteria such as the BarA-
SirA of Salmonella, VarS-VarA of Vibrio, GacS-GacA of Pseudomonas, ExpS-ExpA 
of Erwinia species, all of which were involved in virulence of the respective bacteria 
[148, 149, 183] .  Part of the downstream effect of such TCS is often mediated via a 
global regulatory RNA binding protein known as Csr (Carbon storage regulator in 
Escherichia, Salmonella and Vibrio species) or Rsm (Repressor of secondary 
metabolites in Pseudomonas and Erwina species).  The response regulator 
UvrY/GacA controls expression of few non-coding RNA which in turn, binds to 
CsrA/Rsm regulator and titrates its activity.   
The BarA/UvrY/Csr signaling cascade in Escherichia coli is involved in adaptive 
response of diverse physiological process including carbon metabolism, motility, 
biofilm formation and virulence.  The BarA-UvrY TCS is involved in switching 
between metabolic pathways and balances carbon flow via CsrA activity in E. coli 
[164].  The downstream effect of this TCS is mediated via Csr (Carbon Storage 
Regulator) system whereby uvrY positively regulate expression of two non-coding 
RNA, CsrB and CsrC which in turn sequesters CsrA, the global regulatory protein, by 
binding to it.   The consensus sequence for CsrA binding seems to be conserved GGA 
motif usually present in the stem loop or hairpin or linear region of the transcripts.   
Adaptation signals called autoinducers are involved in gene expression in a 
population-dependent manner.  In E. coli, the synthesis of Autoinducer 2 (AI-2) is 




conserved LuxR-type domain commonly associated with Quorum Sensing is present 
in UvrY.   
In this study, we showed that the mutation of the BarA-UvrY TCS reduced 
expression of a merodiploid reporter strain luxS-lacZ whereas loss of csrA, displayed 
a concurrent increase in expression of the reporter in a growth phase dependent 
manner.  AI-2 levels were correspondingly synchronized with reporter activity 
specifically from mid-log to entry of stationery phase.  The uptake of AI-2 takes place 
by an ATP-dependent transporter lsr (luxS regulated), expression of which is 
modulated by this signaling cascade in an opposite manner as compared to AI-2 
levels and reporter activity, suggesting a balance of carbon flow at the entry of 
stationery phase.   Direct regulatory interactions of CsrA with luxS transcripts 
furthermore confirmed the post transcriptional control of CsrA.  Loss of hfq also 
reduced the exprerssion of reporter activity suggest association of small RNA in this 
regulation.  These findings suggest a complex interplay of BarA/UvrY/Csr signaling 
pathway in a crucial pathway for adaptation by population dependent gene expression 
in E. coli.  
Materials and Methods 
Strains, plasmids and phages  
The bacterial strains, plasmids, and bacteriophages used in this study are                 




Chemicals and Reagents 
Most of the chemicals were bought from Fisher Scientific (Pittsburg, PA) and Difco 
(Sparks, MD). Antibiotics were bought from Sigma (St. Louis, MO), restriction 
enzymes, ligases, from NewEngland Biolabs (Beverly, MA), Taq Polymerase, Hifi 
Taq, and Pfu Polymerase, nucleotides for PCR from Invitrogen ( Carlsbad, CA), Tgo 
Polymerase and CyberGreen RT-PCR kit from Roche Applied Sciences 
(Indianapolis, IN), plasmid DNA, PCR purification, gel extraction, RNA purification 
kits from Qiagen (Valancia, CA), DNAse, RNAse, and RNAse-free water from 
Ambion (Austin, TX). Oligonucleotide primers were purchased from Invitrogen. 
Radioactive nucleotides were purchased from Amersham Pharmacia Biotech 
(Piscataway, NJ ). 
 
Media and growth condition 
All media was prepared as described in Miller [201]. Luria Bertani medium was used 
for routine cultures (10 gl-1 tryptone, 5 gl-1 yeast extract, 10 gl-1 NaCl, pH 7.0) and 
Tryptone Broth (10gl-1 tryptone, 5gl-1 NaCl, pH 7.0) was used for growing strains 
harboring λ fusions.  Selection of phage λ lysates and platings were done in R 
medium (10 gl-1 tryptone, 1 gl-1 yeast extract,  5 gl-1 NaCl, 2x10-3 M CaCl2 and 0.1% 
glucose).  M9 minimal media ( Na2HPO4 6 gl-1 , K2HPO4 was used for glucose 
induction assays supplemented with 0.1% casamino acids as a C-source for cultures 
that were grown in the absence of glucose. M63  medium was used to select for rel+ 
transductants when transducing barA mutation from MC4100 into MG1655Δlac 
strain [162]. V. harveyi strains were grown in AB medium  (17.5 gl-1 NaCl, 12.3 gl-1 




phosphate (pH 7.0), 1x 10-3 M L-arginine, 1% glycerol [202]. Plates were 
supplemented with 50μg ml-1 of 5-bromo-4-chloro-3-indolyl-β-D- galactopyranoside 
(X-gal) for visualization of β-galactosidase activity.  The following antibiotics were 
added as required at the given concentration: ampicillin 100 μg ml-1, 
chloramphenicaol 20 μg ml-1, kamamycin 50 μg ml-1, streptomycin 50 μg ml-1, and 
tetracycline 10 μg ml-1. Overnight cultures, starting from a single colony, were grown 
in test tubes with 5 ml of medium shaken on a rotary drum at required temperature. 
For proper growth, all experimental cultures were grown in baffled flasks with 1/5 
volume of media at 150 r.p.m in shaking water bath set at appropriate temperature 
(37oC or 30oC). Growth was monitored using a Shimadzu UV-1601 
spectrophotometer at 600 nm (OD600). For gene expression experiments, overnight 
cultures were diluted 1:100 and serially subcultured two times to an OD600 of 0.3, 
before inoculation into pre-warmed fresh media to an initial OD600 0.05.  
 
Recombinant DNA techniques 
Standard molecular techniques were used for transformation, elctroporation, 
restriction enzyme digestion, gel electrophoresis, PCR amplification, Northern and 
Southern Blot analysis.  All amplifications for cloning were done using Tgo 
Polymerase (Roche, Indianapolis, IN) and other amplifications were done using Taq 
or Pfx Polymerase (Invitrogen, Carlsbad, CA) from chromosomal DNA prepared 
from MG1655 strain using Wizard Kit (Promega, Madison, WI). All clones were 




The barA gene was cloned by amplifying the 3.2-kb barA locus from MG1655 with 
OSM 5’CCCGAATTCATA GCATACGCCAAAATGAGGACAG3’ and OSM  
5’CCCGATATCATA ACTCGACAAGACATCCATTA 3’ with a 5’EcoR1-
3’EcoRV restriction site. The resultant product was cloned into pCR2.1 using DNA 
Topoisomerase meditated ligation using the TOPO-TA cloning system (Invitrogen). 
A 3.2-kb EcoR1-EcoRV fragment was subcloned within the EcoR1-EcoRV sites of 
pBR322. The barA ORF is in the direction of the tet gene of the vector. The uvrY 
gene was amplified with additional 178-bp 5’ sequence just before the divergent yecF 
promoter using primers OSM64 5’-
CCCGAATTCATAATTTCATCGTAGGGCTTACTGTGA -3’ and OSM74 5’-
CCCCTGCAGATGCACGCCTGGCTGGTTAC - 3’. The amplified product was 
cloned using TOPO-TA cloning method into vector pCR2.1 (Invitrogen). Few clones 
were sequenced to confirm intact amplification. A 700-bp BamH1-EcoRV fragment 
was cloned within the BamH1-EcoRV site of pBR322, with the open reading frame 
of the uvrY gene oriented in the same direction as the tet gene in the vector. The luxS 
gene (denoted as ygaG, b2687) was similarly amplified using OSM34 5’- 
GTGAAGCTTGTTTACTGACTAGAT - 3’ and OSM35 5’- 
GTGTCTAGAAAAACACGCCTGACAG - 3’ and cloned into pCR2.1, pluxS14. A 
700 bp EcoR1 fragment was clone into pBR322 where the luxS ORF is in the same 







P1vir transductions were performed as described by Miller [201].  For transduction of 
the barA::kan and barA::lacZ from MC4100 into MG1655, special precaution was 
taken not to select for relA mutation, which is only 1.4 kb from the barA locus as 
selecting transductants that could grow on M63 supplemented medium [192]. 
 
Construction of chromosomal insertional mutants 
The uvrY and the luxS genes in MG1655 were disrupted using Datsenko & Wanner 
method. The uvrY gene was knocked with a chloramphenicaol cassette from plasmid 
pKD3, using linear amplified DNA with 36 bp flanking region of uvrY gene using the 
primers OSM-43 5’-
TGGTGCCGCCAGGGATACGACGCATTCTGGAAGTTGCATATGAATATCCT
CCTTAGT -3’ and OSM-44 5’-
CATTTGTTGAGCGATGTCAGAAGCAATGTAACGCTGACCGTGTAGGCTGG
AGCTGCTTC -3’. The luxS gene was similarly knockout with a kanamycin cassette 
with 36-bp flanking region with primers OSM-49 5’-
TGCGCTTCTGCGTGCCGAACAAAGAAGTGATGCCAGTTGCATATGAATAT
CCTCCTTAGT -3’, OSM-50 5’-
CACGCTGCTCATCTGGCTGTACCAATCAGACTCATATACTGTGTAGGCTGG
AGCTGCTTCG -3’.  The mutations were transduced into fresh background and 




Construction of chromosomal luxS::lacZ transcriptional fusion.   
A 469 bp fragment encompassing 290-bp upstream regulatory sequences region and 
59 codons of luxS gene was PCR amplified with Tgo Polymerase from MG1655 
chromosomal DNA using primers OSM-53- 5’-
CCCGTCGACATAGCATTTGCAGAAGCCTACCGTA-3’(SalI, 139 bp within 
3’end of the gsh gene) and OSM54-
5’CCCGGGCCCATACAAACAGGTGCTCCAGGGTATG3’(SmaI, 179 bp within 
the luxS gene).  The amplified fragment was cloned within the SalI-SmaI site of 
promoterless lacZ transcriptional fusion vector pSP417, a modified pRS415 vector 
with extended multiple cloning sites. The clones were sequenced to check the 
integrity of the amplified fragment and the fusion junction. The plasmid-borne fusion 
was transferred to λRS45.  The resulting recombinant phage, λPluxS-lacZ (λSM001) 
was used to transfer the fusion into MG1655Δlac, creating a merodiploid luxS+ luxS-
lacZ fusion (SM105). Single-copy fusions were isolated and verified by a Ter assay 
followed by measurement of β-galctosidase activity.  
 
Autoinducer Bioassay 
The detection of AI-2 in cell-free supernatant was performed using a Vibrio harveyi 
reporter system.   Vibrio harveyi BB120 was the wild type for this assay. The reporter 
strain BB170, a luxN mutant of BB120 was sensitive to AI-2 but not to AI-1. V. 
harveyi was cultured in autoinducer bioassay (AB) medium.  The positive controls 
were either BB152 (AI-1-, AI-2+) or BB120 (AI-1+ AI-2+) and the negative control 




Relevant strains were grown in 5ml AB media overnight for 16 hrs in duplicates at 
30oC.  The cells were pelleted by centrifugation at 10,000g for 2 min.  The cell-free 
culture supernatant so obtained was then passed through a 0.22 mm filter (Millex-
GS).  The overnight reporter was diluted 2500 times in AB media typically, 10μl 
reporter in 25ml AB media, to cancel out the background luminescence due to the 
reporter itself.  The assay was performed in white 96 well microwell plate (Nunc, 
Denmark).  The ratio of cell-free supernatant to that of diluted reporter was 1:9 and 
typically 20μl of cell-free supernatant was used with 180μl of diluted reporter.  
Higher volume/well ratio was used to reduce fluctuations in luminescence and light 
scattering.  The plates were incubated at 30oC with mild shaking.  Bioluminescence 
was monitored every 30 or 60 minutes in either mediators PhL luminescence 
microplate reader or by a VICTOR3™V Multilabel Counter (PerkinElmer).  Each 
cell-free culture supernatant was assayed at least three times and the mean values 
were reported.   
 
Saturation Assay 
For this assay, an increasing volume of cell free supernatant was used to achieve light 
saturation.  Cell-free supernatant starting from 5, 10, 25, 50, 60 and 70 μl was added 
to a fixed volume (50μl) of diluted reporter (1:2500).  The ratio of diluted reporter to 
CFS would vary throughout the saturation curve. The  various ratio of reporter to CFS 
 would be  50:5  or  10:1, 50:10  or 5:1, 50:25  or 2:1, 50:50  or 1:1  (Saturation 
occurs at 1:1) , 50:60  or 1:1.2 and 50:70  or 1:1.4. The Kd for saturation curve was 




For the AI-2 kinetics assay, we used a ratio of diluted reporter (180μl) to cell free 
supernatant (20μl) as 18:2 or 9:1.  Hence the ratio that would be closest between the 
two assays would be the first one of saturation to that of the kinetics assay 
respectively. i.e. 10:1 to 9:1.  Thus for comparing the first dilution the reported value 
of AI-2 in kinetics assay should be multiplied by 10/9 to compare with the saturation 
curve, given the ratio of reporter to CFS works linear at all volumes.
 
RNA stability assay 
Total RNA was isolated at an OD600 at which CsrA activity is optimally expressed. 
Rifampicin (Sigma Aldrich) was then added to the culture medium at a final 
concentration of 500 μg/ml to inhibit transcription initiation.  Rifampicin prevents 
initiation of new transcripts by binding to the β subunit of RNA polymerase.  
Samples were then removed at 2.5, 5, 7.5 and10 minutes after addition of rifampicin. 
Amount of remaining luxS mRNA was calculated from the intensities of the bands by 
normalizing with intensities of icd, housekeeping gene.  The cells were harvested at 
14,000 rpm in a microcentrifuge and frozen in solid CO2-ethanol, with no more than 2 
min allowed to elapse between sampling and freezing.  
 
β−galactosidase activity 
Strains were grown overnight in TB media with appropriate antibiotics.  The 
overnight cultures were subcultured 1:100 in fresh TB media with antibiotics and 
were allowed to grow at 37oC water bath until an O.D600 of 0.4-0.6 is reached.  The 




achieved. 100μl of the cultures were aliquoted periodically, vortexed and stored in 
900μl of Z buffer at 4oC.  200μl of ONPG was added to the aliquots to initiate the 
reaction, mixed and starting time was noted.  Once a sufficient yellow color develops, 
the reaction was stopped by adding 0.5ml of a 1M sodium carbonate solution and 
finishing time recorded.  The solution is then centrifuged at 11,000 rpm for 2min and 
O.D420 was measured.  The β-galacatosidase activity was reported as follows: 
 
Units of β-galactosidase =      1000      X          O.D420 
                                             Time X Volume X O.D600 
 
 
Gel Shift Assay 
Interaction between luxS transcripts with CsrA protein was demonstrated by gel 
retardation assay.  Briefly, templates were prepared by PCR amplification of the 
leader region of luxS using primers OSM317 and OSM318 such that the transcripts 
contain a minimal T7 promoter sequence upstream to the transcription start site. The 
PCR amplified products were gel purified and quantitated by A260/A280 and visualized 
on 0.7% agarose gel in TE buffer.  50ng of template was used for in vitro 
transcription in a total volume of 20μl.  In vitro transcription was performed in 
accordance with MAXIscript (Ambion, CA) protocol.  The transcripts so generated 
were gel purified and dephosphorylated prior to end labeling with [γ- 32P] ATP using 
T4-polynucleotide kinase.   The labeled transcript was then heated at 80oC and slowly 
allowed to cool at room temperature to permit formation of secondary structures.   
Binding reaction condition employed 30 pm labeled RNA with increasing 




The binding buffer for this reaction includes 10mM Tris-HCl (pH 7.5), 10mM MgCl2, 
100mM KCl, 32.5ng yeast RNA, 10mM DTT, 10% glycerol, 4 U of RNase inhibitor 
in a 10μl volume.  Cold RNA was also included in the reaction mix. The reaction mix 
was allowed to incubate at 37oC for half an hour.   The samples were fractionated in 
6% native polyacrylamide gels. Gels were dried and radioactive bands were 
visualized using a phosphorimager.   
 
Results 
Growth rate impaired on barA, uvrY and luxS mutants 
The barA and uvrY genes were disrupted in E. coli MG1655 using λRed recombinase 
system. The barA::kan insertion mutants probably did not have polar effect on the 
relA gene by their ability to growth in M9 suplemented medium. However, the colony 
morphology of both the mutants were smaller than the wild-type strain when grown 
in TB agar plates or minimal media, but not so much on LB agar plates. The growth 
rate defect was more in the uvrY mutant (G = 34.5 min) than the barA mutants (G = 
29.5 min). The defect was observed in the exponential phase and amplified when 
grown in minimal medium or nutrient poor medium (TB) (barA= 40.2 min and uvrY 
= 53.1 min compared to 35.2 min of the wild-type strain) as compared to DH5α (luxS- 
relA-) (G = 35.1 min and 40.2 min), a known slow growing strain as a reference 
control (Figure 6).  The growth rate defect of csrA was minimal.  Thus this defect 
could be due to nutritional utilization deficiency or could be due to accumulation of 





Accumulation of exogenous AI-2 on mutation of barA, uvrY and csrA genes  
The synthesis of AI-2 is dependent on LuxS enzyme catalyzed reaction from S-
ribosyl homocysteine to homocysteine in methyl cycle (Figure 5).  Each cycle 
generates one AI-2 molecule and thus AI-2 activity could be a potential indicator of 
cellular metabolism.  Several cues indicated potential involvement of the 
BarA/UvrY/Csr system in luxS based AI-2 signaling.  Firstly, UvrY also have a LuxR 
type domain commonly associated with binding of autoinducers (Figure 3) 
Secondly, several studies have also indicated that expression of small RNAs CsrB 
and CsrC increases with cell population density [192, 203].  Thirdly, E. coli is not 
known to have LuxI type homologue which synthesizes autoinducer-1.  Finally cell-
cell communication plays an important role in virulence and efficient adaptation 
inside host.  These have led us to assess whether BarA-UvrY TCS had an effect on 
AI-2 signaling in E. coli.  Vibrio harveyi reporter BB170 was used to detect AI-2 
activity from cell-free culture supernatant.  This reporter has a mutation in luxN, and 
impaired in AI-1 detection but a fully functional luxQ which specifically detects AI-2 
activity.   
 
Our results indicated accumulation of AI-2 in cell-free culture supernatants grown in 
LB is growth phase dependent as reported previously [204].  Mutation in the barA, 
uvrY, or both genes reduced exogenous AI-2 accumulation in E. coli MG1655 (Figure 
7). Compared to isogenic luxS::kan mutant strain, the wild type strain produced 300- 
fold higher AI-2 at late exponential phase. The accumulation of AI-2 in the barA or 
uvrY mutant background was several fold (~3 fold) lower than wild type strain in 




complemented in the mutant with ectopic expression of barA or uvrY from a plasmid. 
Although the relative amount of AI-2 accumulation in the complemented stain was 
similar to the wild-type, the accumulation of AI-2 in supernatants was slightly 
delayed.  The effect was more severe in an uvrY mutant with lower AI-2 
accumulation in mid-exponential phase and in early stationary phase.  In the 
complemented strain, the extracellular AI-2 accumulation was similar to the mutant 
mid-exponential phase indicating that over-expression of UvrY may be initially 
limiting AI-2 accumulation. However, the complemented strain exhibited higher level 
of AI-2 accumulation than AI-2 wild type strain during late exponential-phase.  
 
Effects of BarA/UvrY/Csr signalling cascade on luxS::lacZ transcriptional fusion 
Since a disruption of the luxS gene caused a gowth-defect, we constructed a 
merdiploid strain with a single-copy luxS::lacZ transcriptional fusion with 290-bp 
upstream sequence from the luxS ATG codon.  A single copy fusion integrated within 
the λ att site of the E. coli chromosome was selected to study luxS expression under 
various experimental conditions in LB and TB medium. 
 
The luxS::lacZ transcriptional fusion exhibited a growth-phase dependent expression 
similar to the extracellular AI-2 accumulation. The expression of the luxS::lacZ 
fusion in a barA mutant was found to be 2-fold lower in mid-exponential phase and 
about in early-stationary phase as compared to the wild type strain. The level of 
expression could be complemented to a large extent but not similar to the wild type, 




fusion was higher in an uvrY mutant and it was only 2.5-fold lower than wild type in 
mid-exponential and stationary-phase.  These results suggest that the BarA-UvrY 
two-component system, in part, regulates growth phase dependent luxS expression, 
more so in the exponential phase than in the stationary phase.  The moderately higher 
level of basal transcription of the fusion in absence of UvrY indicates that there may 
be additional factors involved in the regulation of luxS expression in stationary phase. 
 
Regulatory interaction of CsrA with luxS transcripts 
On the other hand, mutation in the downstream global regulator, csrA showed 
approximately 4-fold upregulation of AI-2 activity and 6-fold upregulation of 
luxS::lacZ chromosomal reporter activity which could be restored to wild-type level 
upon complementation (Figures 7 and 8).  The repression of CsrA takes place at the 
entry into the stationery phase, and is coincident at which the BarA/UvrY TCS shows 
induction of luxS expression. The repression of AI-2 by CsrA is growth phase 
dependent and entry into the stationery phase displayed a sharp decrease of AI-2 in 
extracellular milieu.  This suggested a probable post-transcriptional regulation of luxS 
by the Csr system.    
 
The regulatory role of CsrA on luxS transcript is further explored by assaying luxS 
transcript stability assay.  A csrA mutant displays an increase in transcript stability as 
compared to isogenic wild type.  Mutation in csrA increases luxS mRNA half-life as 
by more than three minutes (Figure 9A).  Secondary structure prediction of luxS 
leader by RNA fold, generated two stem loop region, one of which have a GGA 




CsrA is known to bind leader of various transcripts having multiple binding sites for 
CsrA (such as glgC, pgaA) and thereby inhibit translation efficiency by occluding the 
Shine-Dalgarno sequence. CsrA is also known to bind hfq, which have a single 
binding site.  Furthermore the direct interaction between CsrA protein and luxS leader 
is also displayed by gel shift assay.  A shift was observed between 80 to 160nM of 
CsrA protein (Figure 9C).   
 
Effect of mutation of barA, uvrY and csrA on Lsr transporter 
In E. coli the rapid disppareance of AI-2 from the extracellular milieu was due to an 
ATP-binding cassette, Lsr transporter which is induced upon entry into stationery 
phase.  Glucose is known to repress lsr and as the level of nutrients decreases, lsr is 
induced resulting in a concomitant decrease in AI-2 level from the extracellular 
supernatant.  The role of BarA/UvrY/Csr signaling cascades in the uptake of AI-2 by 
an, Lsr was investigated.   As expected, the lsr activity was minmal until the mid log 
phase and as stationery phase is approached the operon is induced.   The barA and 
uvrY mutants showed a slightly higher level of lsr activity as compared to the parent 
strain.  The csrA mutant in contrast, showed a 4-fold reduction in lsr activity as 
compared to the wild type strain, typically at the entry into stationery phase.  Real 
time RT-PCR also demonstrated a sharp increase in expression in lsrK, lsrA, and lsrR 
upon complementation or over expression of CsrA (Table 2).  Hfq, a RNA chaperone, 
facilitates the base pairing between transcripts and regulates message stability.  A loss 
of hfq also reduced the luxS expression which could be plasmid-complemented, 





Effects of the mutation of uvrY on swarming motility 
Bacterial motility is a complex phenomenon regulated by flagellum regulated by a 
hierarchical cascade starting with the flhDC master operon that encodes tetrameric 
DNA binding regulatory proteins. Since in vitro studies indicate UvrY does not 
directly bind to flhDC promoter, the effect may be either, in part, through the post-
transcriptional activation of the flhDC genes via the BarA→UvrY→CsrB/C→CsrA 
system, or it could be in part via a Csr-independent mechanism.  
 
Swarming, a population dependent flagellar motility is characterized by rapid and 
coordinated group migration over solid surfaces.  The ability to swarming is 
considered a virulence factor and associated with biofilms in several species like 
Proteus mirabilis and Salmonella typhimurium.  Swarming requires cell-cell 
communication for migration over a wet solid surface as a group. A loss of uvrY also 
demonstrated reduced swarming motility in semi-solid agar media in presence of 
glucose.  The defect could be restored upon complementation (Figure 11).  However, 
E. coli K-12 does not show good swarming partly because of a lack of fully 
functional O-antigen.  A luxS mutant also displayed a reduction in swarming ability 
(not shown).  
 
Discussion 
The BarA/UvrY TCS has been shown to regulate central carbon metabolism via 




metabolic switch between glycolytic and gluconeogenic pathways.  BarA-UvrY 
orthologues are conserved in the γ-subdivision of proteobacteria, and plays a role in 
regulating secondary metabolism in E. coli, Pseduomonous fluorescens, Azotobacter 
vinelandii, and Vibrio fischeri.  This study shows that in E. coli,  AI-2 sysnthesis and 
uptake is controlled by the BarA/UvrY/CsrA signaling cascade at transcriptional and 
post-transcriptional level for efficient utilization of carbon flow into the cell.  The 
BarA/UvrY/Csr system regulates luxS expression and AI-2 activity. 
 
Autoinducer 2 (AI-2) is generated as a by product of activated methyl cycle.  The 
methyl-cycle is an important metabolic detoxification-recycling loop for s-
adenosylmethionine (SAM).  The cycle detoxifies s-adenosylhomocysteine (SAH), 
formed post-methyl donation from SAM, by breaking it down by PfS to generate S-
ribosylhomocysteine. LuxS then recycles homocysteine back into the cycle for 
generation of SAM, in the process generating 4,5-dihydroxy-2,3-pentanedione 
(DPD), a precursor of AI-2.  It is assumed that AI-2 crosses the outer-membrane and 
accumulates to a threshold concentration before they trigger a cellular QS response 
via one or more receptors, including the QseB-C system.  The role of BarA-UvrY in 
QS has not been tested. The exact nature of signal detected by the BarA-UvrY TCS is 
presently unknown, even though it seems to be pH dependent. However, recent 
findings in Pseudomonas, and Vibrio fisheri indicated that it is highly possible that 
this two-component system may be one of the regulating factors for luxS-mediated 
QS in E. coli.  Both the autoinducers, AHL and AI-2, positively regulate 




proteobacteria similar to E. coli. A gacA (uvrY) deletion mutant of V. fischeri exhibit 
no detectable luminescence in liquid culture. Addition of known inducers of 
luminescence, specific AHL (AI-1), marginally complemented the defect.   The 
defect was neither due to reduced synthesis of AHL indicating that the defect in 
luminescence in the gacA (uvrY) mutant was affected by AHL-independent 
mechanism.  However, unlike V. fischeri, E. coli does not have a known functional 
AHL synthesis pathway which UvrY orthologues are known to regulate.  Secondly, 
we also detect impairment in the ability of an uvrY mutant to swarm in semisolid 
agar.   Swarming motility is dependent on coordination among members of a group of 
bacterial species and is dependent on QS.  Thirdly, UvrY also have a characteristics 
LuxR type domain commonly present in proteins involved in Quorum Sensing.   
Thus, we hypothesized that, UvrY (GacA) and BarA may be regulating AI-2 
synthesis.    
 
The AI-2 synthesis was maximum in early stationary-phase and declined thereafter as 
reported earlier even though the luxS expression remained constant at a basal level.  
In the barA::kan mutant, there was a ~ 10-fold reduction of AI-2 in mid-exponential 
phase and ~ 6-fold reduction in early stationary phase. The AI-2 accumulation could 
be restored by carrying the barA gene in trans.  Similar result was obtained in an 
uvrY::cm mutant strain, with ~8-fold and 3-fold reduction of AI-2 in mid-exponential 
and early early stationary phase respectively.  The background levels of AI-2 was 
slightly higher than the in the barA mutant.  The level of AI-2 was upregulated atleast 




transcriptional regulation.  CsrA affects stability of various target transcripts and here 
we showed that mutation of csrA indeed increased transcript stability of luxS mRNA.  
Furthermore, computational prediction of luxS leader indicated a stem loop occluding 
the RBS site and contains a conserved GGA bindite site in the loop of the hairpin.  
Gel shift analysis furthermore demonstrated that the effect of CsrA is direct.   The 
involvement of small RNA in this regulation is also another possibility as an hfq 
mutant displayed reduced expression of luxS.   
 
This study shows in E. coli, the BarA/UvrY/CsrA signaling cascade regulates luxS 
expression and consequently AI-2 accumulation in extracellular environment in a 
growth phase dependent manner.  The BarA-UvrY TCS regulate carbon metabolism 
and switches between gluneogenic pathways for efficient adaptation through the 
activity of CsrA.   Here we demonstrate a similar effect by the BarA/UvrY TCS in 
regulation of luxS expression and AI-2 accumulation.  The regulation of luxS by the 
signaling cascade suggests a balance between synthesis and uptake of AI-2 (Figure 
12A).  AI-2 is a 5-carbon moiety furanone, which we propose to be efficiently 
utilized by the Csr system at the onset of stationery phase.  In this model, at low cell 
density CsrB and CsrC is not optimally expressed and increasing free CsrA leads to 
tight repression of luxS.  The expression of small RNA CsrB and CsrC is under 
positive control of UvrY.  However with increasing cell population density, there is 
an increase in transcription of small noncoding RNA CsrB and CsrC, which titrates 
free CsrA in the cell.   This in turn relieves the repression of luxS and consequently 




peaks at the entry of stationery phase.  Once cells reach into the stationery phase, Lsr 
transporter is induced which internalizes the AI-2 from extracellular environment. 
CsrA also stimulates Lsr transporter activity starting from entry into stationery phase.  
CsrD an endonuclease which facilitates RNAse E mediated decay of CsrB and CsrC 
small RNA.  Once these small RNAs are decayed, the level of free CsrA once again 
increases in the cell, presumably deep into the stationery phase. Thus once the cells 
enter into the stationery phase, CsrA represses luxS, and thereby reducing the 
synthesis of AI-2 while simultaneously induces Lsr transport system and thereby 
increases uptake of AI-2 into the cell.  Thus, in a csrA mutant higher level of AI-2 is 
detected in extracellular environment which falls exponentially deep into the 
stationery phase due to induction of Lsr transporter.  This could mean that AI-2 could 
be used as a nutrient once the cell enters in the stationery phase while balancing the 
flow of carbon by the global regulatory protein, CsrA.  Alternatively, AI-2 induced 
genes have to be controlled in a population dependent manner and may not 
necessarily remain induced deep into the stationery phase. In nutshell, the BarA-
UvrY TCS alongwith Csr system regulates luxS expression both at transcriptional and 
post-transcriptional level.   This suggests a complex interplay of the BarA/UvrY/Csr 
in regulation of luxS expression, AI-2 synthesis and uptake in E. coli (Figure 12B).   
 
Metabolic adaptation is achieved via a network of different signals at different stages 
of growth and adaptation modulating gene expression.  These signals might be 
interacting with one or more sensor kinases that direct gene transcription for 




understand exact basis and nature of BarA/UvrY and CsrA in the methyl cycle-
regulation, one central outcome of these studies indicate that BarA/UvrY TCS 
regulates E. coli metabolism, communication activities, and nutrient acquisition, an 




Figures and Tables 
Figure 6.  Growth curve of the barA, uvrY, csrA and luxS mutants.  The mutants 
displayed growth defect which could be restored upon trans complementation. 
Mutation in luxS displayed a marked reduction in growth rate. The growth defect was 


























































































Figure 7.  Exogenous accumulation of AI-2 in barA, uvrY, csrA and luxS mutants. 
The barA or uvrY mutants displayed a reduced accumulation of AI-2 whereas the 
csrA mutant displayed a conincidental increase in AI-2 activity at the entry of 
stationery phase.  Furthermore, Kd of uvrY and csrA mutant was also reported and 
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Figure 8.  Effect of mutation of the barA, uvrY or csrA genes on the activity of single 
copy luxS::lacZ transcriptional fusion.  Mutation in barA or uvrY demonstrated 
reduced activity of luxS::lacZ reporter activity, whereas csrA mutant displayed an 
increased reporter activity, both of which could be restored to wild type level upon 





















































































Figure 9.  Regulatory interaction of CsrA with luxS transcript.  
A.  Transcript stability of luxS mRNA. Rifampicin was added to block transcription 
and luxS message stability was assayed for 10 minutes.  Mutation in csrA showed 
relatively stable message (4.75 minutes) as compared to the wild type (1.25 minutes).  
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B.  Predicted structure of luxS mRNA leader. The most stable predicted structure 
indicated two hairpins, one of which occludes the ribosome binding site with a GGA 


















































C.  Gel Mobility shift analysis of CsrA-luxS leader interaction.  5’- end labeled luxS 
leader transcript was incubated with CsrA at concentration as shown below each lane. 














Table 2.   Effect of mutation of the BarA/UvrY/CsrA signaling system on Lsr 
transporter activity.  Mutation in csrA showed approximately four-fold repression of 










Relative mRNA level                          β - galactosidase
(Miller units)
lsrk lsrR lsrA plsr::lacZ
wt 100 100 100 40.8 + 3.5
barA::kan 98.0 + 2.0      95.0 + 1.5     96.0 + 1.0 55.1 + 3.0
uvrY::cm 83.0 + 1.5      34.0 + 1.5     90.0 + 1.0 58.6 + 3.5





Figure 10.  Effect of mutation of hfq on luxS::lacZ reporter activity.  Mutation in hfq 
reduced reporter activity at the entry of stationery phase and subsides once deep into 











































































Figure 11.  Impairment of swarming motility upon loss of uvrY on semisolid agar.  












Figure 12.   Proposed regulatory circuit of AI-2 synthesis and uptake in E. coli.  
A.  Regulation of AI-2 activity by balance of carbon flow. At low cell density the 
CsrB and CsrC is not optimally expressed leading to a tight repression by CsrA on 
luxS.  However expression of CsrB and CsrC increases with population density and 
consequent titration of free CsrA leads to derepression of luxS and more accumulation 
of AI-2 in the extracellular environment.  CsrA also induces the Lsr transporter 
involved in AI-2 uptake and thereby balances the flow of carbon at the entry into 










































B.   QS circuit in Escherichia coli.  The BarA/UvrY TCS regulates luxS expression 
positively at transcriptional level whereas CsrA negatively regulates luxS post-
transcriotionally.   A possible role of quorum sensing regulatory RNA exists in the 
circuit.  The sensing stimulus of the BarA/UvrY TCS is unknown at the moment.  






















Chapter IV:  Biofilm formation in Uropathogenic Escherichia 
coli is influenced by the transcriptional regulator, uvrY in a type 
1 pilus dependent manner 
 
Abstract 
Biofilm formation is an important virulent determinant in Urinary Tract Infections.  
Uropathogenic E. coli are the principal causative agent in community and hospital 
acquired UTI.  Several factors contribute to biofilm formation among which Type 1 
pili, Pap pili, production of exopolysaccharides, flagellar associated motility are 
critical in E. coli.  We studied the role of transcriptional regulator uvrY in biofilm 
formation in Uropathogenic Escherichia coli.  Absence of uvrY cause reduced 
expression of fimA and papA, fimbrial major subunit of Type 1 Pilus and Pap pilus 
respectively. Using PCR Inversion Assay we demonstrate that uvrY  regulates phase 
variation of Type 1 pilus.  Furthermore, acidic exopolysaccharide accumulation and 
the ability to swarm are also being impaired by deficiency of the regulator.  Finally, 
uvrY mutants demonstrate a lack of colonization in kidneys and bladders in an 
ascending model of UTI.  Overall, the effect of uvrY on biofilm formation seems to 







The ability of bacteria to adapt and colonize is critical for survival and persistence of 
bacteria in a dynamically changing environment. Bacterial adaptation to new 
environment relies on a signaling cascade called two-component regulatory systems 
(TCS).   A two-component system consists of a sensory protein kinase (HPK) and a 
cognate response regulator (RR).  The sensor kinase is involved with detection of 
environmental cues which is transduced to the response regulator.   The response 
regulator, in turn, responds by appropriate modulation of gene expression.   
Around thirty TCS have been recognized in Escherichia coli out of which the BarA-
UvrY two-component regulatory system have been shown to be strongly linked with 
virulence.   In this system, BarA is the sensor kinase and UvrY is the cognate 
response regulator.  Several orthologues of this TCS are present in diverse species of 
γ−division of proteobacteria including BarA-SirA of Salmonella, GacS-GacA of 
Pseudomonas, VarS-VarA of Vibrio and ExpS-ExpA of Erwinia,  all of which have 
been demonstrated to be strongly involved with virulence.   
 
Biofilms contribute up to 80% of chronic inflammatory diseases including urinary 
tract infections (UTI), cystic fibrosis, otitis media, colitis, conjunctivitis, dental 
plaque, endocarditis, peridontitis, and prostatitis [88].  Presence of biofilms in 
indwelling medical devices (such as urinary catheters) and other devices in healthcare 
settings often results increase incidence of nosocomial infections.  Uropathogenic E 
coli (UPEC) are commonly associated with community and hospital acquired Urinary 




the ability to form biofilms.  In E. coli several adhesins such as Type 1, 
exopolysaccharide accumulation and flagellar associated motility is critical for 
biofilm formation.  In this study, we decided to investigate the contribution of the 
response regulator uvrY in Uropathogenic Escherichia coli by evaluating pilus 
expression, exopolysaccharide accumulation and flagellar motility that are critical for 
biofilm development. 
 
Materials and Methods 
 
Bacterial Strains, Plasmids, Primers 
All bacterial strains, plasmids, primers are listed in Tables 6 and 7.  
 
Cloning of functional uvrY gene   
Relevant genes were disrupted in UPEC CFT073 using λ Red recombinase system. 
The uvrY gene was amplified with 178 bp 5’ sequence just before the divergent yecF 
promoter using primers OSM 64 5’ 
CCCGAATTCATAATTTCATCGTAGGGCTTACTGTGA 3’ and OSM 65 5’ 
CCCCTGCAGATGCACGCCTGGCTGGGTTAC 3’.  The amplified product was 
cloned using TOPO-TA cloning method into vector pCR2.1 (Invitrogen). Few clones 
were sequenced to confirm intact amplification. A 700-bp BamH1-EcoRV fragment 
was cloned within the BamH1-EcoRV site of pBR322, with the open reading frame 




Cloning of uvrY gene for over expression and purification of the UvrY protein 
The uvrY gene was cloned at BamH1-Pst1 site of the multiple cloning sites in pQE30 
(N- terminal 6x His) vector.  The clones were sequenced and checked for the 
presence of His-tag sites and subsequently transformed in pREP4 for expression 
studies and protein purification. The 6His-Tag UvrY have been purified on a small 
scale. 
 
Biofilm Assays (Growth Conditions) 
Overnight cultures of Escherichia coli in LB broth with appropriate antibiotics were 
subcultured (1:100) in 50 ml LB broth with necessary antibiotic and grown at 37oC 
for 1 hour. The cultures were then transferred to Petri-plates (Falcon, 150X15m) 
containing 8-12 sterile borosilicate cover slips and in microtiter plates.  The plates 
were incubated at room temperature.  Media was periodically removed every 24 
hours, washed with 20 ml of 1X Phosphate buffer saline (PBS) (pH 7.4) and fresh LB 
media with antibiotics were added.  
 
Crystal Violet Staining  
Coverslips were taken out of the Petri-plate and washed thoroughly by dipping in 1X 
PBS (pH 7.4) buffer. They were taken in fresh Petri-plate (96X16mm) and dry-fixed 
for 1 hour at 60°C. 10 ml of 0.1% CV (SIGMA Chemicals, MO, USA) in 
isopropanol: ethyl alcohol: PBS (pH 7.4) (1:1:18) were added to the coverslips in the 
Petri-plates and were allowed to stand at room temperature for 15 minutes. Excess 
crystal violet was  then removed by washing cover slips at least  twice with 10 ml of 




broken with a glass cutter and taken in 1.5ml microfuge tubes. 1 ml of 33% acetic 
acid was added to each tube to dissolve the crystal violet dye and the O.D. was 
measured at 570 nm with required dilution.  The same assay was also done in glass 
and PVC microtiter plates. 
 
Ruthenium Red Staining   
The bacteria were grown under the same conditions as previously described in 
150X15mm Petri-plates with sterile cover slips at the bottom of the Petri-plates. Two 
cover slip per plate was removed carefully, washed by dipping in 1X PBS (pH 7.4) 
buffer in a beaker, fixed at 60°C for 1 hour and placed in a well of a 6 well tissue 
culture plate. 1 ml of stain I (0.15% ruthenium red-0.5% glutaraldehyde dissolved in 
0.1M cacodylate buffer) was added to each of the wells and allowed to stand at room 
temperature for 1 hour. The stain I was removed and 1 ml of stain II (0.05% 
ruthenium red-0.5% glutaraldehyde dissolved in 0.1M cacodylate buffer) was added 
and allowed to stand at room temperature for 2 hours. Stain II was removed, washed 
five times with 1 ml of 0.1M cacodylate buffer and observed under light microscope 
at either 40X or 100X magnifications. 
 
Assays for fim switch orientation  
The assays for orientation of fim switch was done as earlier described .  In brief, after 
isolation of chromosomal DNA, equal amount of genomic DNA was used as a 
template to determine the “ON” phase and “OFF” phase respectively by using two 




visualized by ethidium staining.  The “ON” and “OFF” population were represented 
by lower band and upper band respectively.  The primers were listed in Table 6.  
 
Hemagglutination Assay  
Relevant strains were grown in LB with appropriate antibiotic as necessary 
(ampicillin 100, kanamycin 50, and chloramphenicol 20) without shaking for three 
passages (48 hrs each).  The assay was carried in a 96 well round bottom plates 
(Costar, Corning, NY) in triplicates.  Briefly, 50μl of PBS were added with and 
without 50mM Mannose in separate lanes of the plate and serial dilution of each 
culture is attained by addition of 100 μl of each cultures, carefully mixing, and then 
transferring 100 μl of the mix into the next well.  The dilution is performed in a 
similar manner till the second last lane. 100μl of mix from the last lane were removed 
from the last lane to achieve appropriate dilution ratio.  Finally, 50μl of human 
erythrocytes (1%) were added to each lane from higher to lower concentration of cells 
to permit more time to visualize a clear agglutination.   The resultant final volume of 
each lane then becomes 100 μl.  The assays were tested on type O+ human, sheep and 
gunieapig blood (Lampire Biological Laboratories, Pipersville, PA). The maximum 
dilution of cells that gives a visible agglutination is reported as the titer.  The plates 






RNA stability assay  
Total RNA was isolated at an OD600 at which CsrA is maximally expressed. 
Rifampicin (Sigma Aldrich) was then added to the culture medium at a final 
concentration of 500 μg/ml to inhibit transcription initiation. Rifampicin prevents 
initiation of new transcripts by binding to the β subunit of RNA polymerase. Samples 
were then removed at 2.5, 5, 7.5 and 10minutes after addition of rifampicin. Amount 
of remaining luxS mRNA was calculated from the intensities of the bands by 
normalizing with intensities of icd. The cells were harvested at 14,000 rpm in a 
microcentrifuge and frozen in solid CO2-ethanol, with no more than 2 min allowed to 
elapse between sampling and freezing. The level of fimA mRNAs declined relatively 
quickly in a csrA mutant strain as compared to a wild type.   
 
Swarming Assay   
Strains were grown under static conditions in LB broth with relevant antibiotics for 
three passages of 48 hours each.   The media for swarming were LB with 0.6% Agar 
(wt/vol) with 0.5% (wt/vol) glucose.  Each experiment was conducted in triplicates.  
Equal number of cells as adjusted by optical density and by colony forming units was 
used for inoculation into the middle of the soft agar plates.  Strains were incubated 
overnight in 37oC.  The diameter of the spread of colonies was measured and 





Confocal Scanning Laser Microscopy (CSLM)    
Coverslips were taken out, washed by dipping in 1X PBS (pH-7.4). They were taken 
in 35 X 10mm tissue culture dish and gently covered with SYTO 9, a fluorescent 
nucleic acid stain that is a part of LIVE/DEAD® BacLightTM Bacteral Viability Kits 
(Molecular probes Inc, Eugene, OR), after diluting the dye four times with water. 
They were incubated in dark at room temperature for 15 minutes. The coverslips were 
washed thrice with 1ml of 1X PBS (pH-7.4), and mounted on slides. The biofilms 
were viewed using a 40X dry objective using a confocal scanning laser microscope 
(CSLM) which is a Zeiss inverted microscope, and a dual laser-scanning confocal 
imaging system equipped with a 100mW argon laser and a 5mW krypton argon laser. 
The thickness of the biofilms was measured from the orthogonal sections of the 
images formed by Z-stack scanning. 
 
cDNA synthesis, quantitative PCR, and quantitative RT-PCR   
Quantitative polymerase chain reaction (qPCR) and quantitative real-time polymerase 
chain reaction (qRT-PCR) were performed as per the manufacturers’ 
recommendations.  Total RNA was isolated using 4ml of liquid culture is stopped 
with 0.9ml stop solution. (Phenol::EtOH - 1::19).  Total RNA was isolated in 
accordance with RNeasy mini protocol (Qiagen, CA) in a final 50μl volume in water.  
Lyzozyme was used in a final concentration of 1mg/ml.  The integrity of RNA as well 
as possible DNA contamination was checked in 1.5% formaldehyde gels and 
spectrophotometrically determined.  Total RNA was subjected to a rigorous DNase 
treatment to remove any possible DNA contamination (Turbo DNA free, Ambion).   




possible trace contamination DNA and OD260/280 ratio were determined for 
subsequent cDNA preparation.  For qPCR, the first-strand cDNA was synthesized 
from 5μg of total RNA using Moloney Murine Leukemia Virus reverse transcriptase, 
Superscript II RnaseH- (Invitrogen, Carlsbad, CA) and 50 ng of random hexamers 
(Invitrogen, Carlsbad, CA) as primers according to manufacturer’s instructions.  The 
quality of cDNA synthesis was determined by electrophoresis in 1.2 % agarose gels 
and quantitation using a Nanodrop ND-1000 spectrophotometer (Nanodrop 
Technologies, Wilmington, DE).  Relevant Internal gene-specific primer pairs were 
designed with a control 16S rrnA gene-specific primers in a 25 μl total reaction 
volume with Taq polymerase in a series of tubes, using a Biometra T-Gradient PCR 
instrument (Biometra, Horsham, PA) for 30 cycles.  At various cycle intervals, a 
gene-specific and a control reaction tube was removed.  Five μl of the reaction 
products were resolved separately in a 1.2% agarose gel, visualized by ethidium 
bromide staining, and the double-stranded DNA (ds-DNA) product intensities 
quantitated using a BioRad Gel Documentation system (BioRad, Hercules, CA).  The 
linear range of amplification for the rrnA gene was from 5-15 cycles in all 
backgrounds, while that of the luxS and the pfs genes were from 12-22 cycles in the 
wild-type strain, and appeared much later cycles for the mutants.  The amplification 
product produced only a distinct 300 bp ds-DNA band.  A qRT-PCR reaction was 
performed on the above set of samples under identical reaction conditions in a Light 
Cycler (Roche, Indianapolis, IN) with SYBER Green-1 PCR Master Mix.  The 
fluorescence signal from SYBER Green intercalation was monitored to quantify 






CBA/J mice were anaesthetized in a chamber by isofluorane (a halogenated volatile 
anaesthetic which induces and maintains general anaesthesia by depression of the 
central nervous system and resultant loss of consciousness).  The innoculum volume 
was carefully adjusted so that there is no forceful inoculation into the kidneys.  
Transurethral inoculation (Harvard pump) involved administration of catheter all the 
way to the lumen of the urinary bladder.  Bacterial strains were grown on 2 large agar 
slants and resuspended in total of 5ml PBS ~ 2x109 CFU/ml. One- half bladder and 
kidney used for histological purposes and one half for spiral plating.  After 3 days the 
mouse were sacrificed, and harvested for the presence of bacteria in kidney and 
bladder.   The mice were handheld and pressed in their neck and abdomen region for 
collection of urine. The urine so collected was weighed, and dissolved in appropriate 




Effect of uvrY on biofilm production in UPEC   
A lack of uvrY shows marked decrease in biofilm production in UPEC CFT073 on 
glass and PVC surfaces (Figure 13).  Part of the downstream effect of the regulator 
uvrY in biofilm formation is mediated by the global regulator, CsrA which represses 
PGA, a basic adhesin. However, complementation of CsrA does restore the uvrY 




surfaces could be due to additional regulation that might be affected independently of 
CsrA.  
 
Effect of uvrY on expression of Type 1 and Pap pilus  
Type 1 pilus is absolutely critical for biofilm formation in Escherichia coli. 
Importantly, Type 1 pili have been implicated in the colonization of the bladder in 
UTI.  On the other hand, Pap pili (Pyelonephritis associated pilus) commonly 
associated with UPEC are important for colonization in the kidneys.   To determine 
whether uvrY have an effect on expression of these adhesins, we tested the expression 
of fimA and papA, the major fimbrial subunit of Type 1 and P pilus respectively by 
semi-quantitative and Real Time RT-PCR.   We have observed both fimA and papA 
being down regulated in the process (Figure 14).  This corresponds to an ability to 
colonize the bladder and kidneys respectively.  
 
Effect of uvrY on fim switch orientation of Type 1 pilus 
Expressions of fimbrial genes are carefully coordinated as it utilizes a lot of cellular 
resources.  An important attribute of Type 1 fimbrial expression is its ability to switch 
between “ON” and “OFF” phase characterized by fimbriated and afimbriated phase 
respectively.  While the ON phase mediate attachment to host cells by interaction 
with surface receptors, the OFF phase shows cell-surface receptors, the afimbriated 
OFF phase may be equally advantageous and might aid invasion through the viscous 
mucus layer that envelop the intestinal epithelium or evasion from phagocytosis by 
macrophages.  The switch between OFF and ON is mediated by a 314-bp invertible 




encoding the major fimbrial subunit.   The invertible element contains the fimA 
promoter element and the orientation of the promoter switches ON or OFF the 
transcription of the Type 1 fimbriae.   Two recombinase termed fimB and fimE, apart 
from other regulators are involved in the regulation of the genetic switch.  The FimB 
can switch from between ON and OFF in either direction, FimE preferentially 
switches from ON to OFF position.   However, environmental signals and DNA 
topology also plays a role in this orientation of the switch.  Mutation in uvrY switches 
OFF the fimbrial population and restores the ON population upon complementation.  
Furthermore, both the recombinase fimB and fimE have reduced expression on loss of 
uvrY.  This could be due to a change in DNA topology upon interaction with the 
upstream regulatory region.  However the downstream effect by CsrA also switches 
OFF the circuit, but unlike uvrY doesn’t restore the ON population and instead the 
OFF population is even further improved.  The fimA message seems to be unstable in 
absence of CsrA, suggesting post-transcriptional regulatory mechanisms affecting 
type 1 pilus (Figure 15).   
 
Effect of uvrY on exopolysaccharide accumulation    
The effect on exopolysaacharide accumulation is further demonstrated by Ruthenium 
Red dye staining.  Ruthenium Red Stain stains the acidic exopolysaccharides.  A lack 
of uvrY shows reduced accumulation of exopolysaccharides which could be 
complemented (Figure 16).   Exopolysaccharide promote adhesion to solid surfaces, 
cell-cell adherence, and stabilization of biofilms structure in E. coli [49, 85, 194, 
205].  Ruthenium red stain, a stain specific for polysaccharides and often used in EPS 




BarA-UvrY TCS regulates the expression of CsrA protein, a major player in 
regulating biofilms formation and EPS production [194]. However, the role of LuxS 
in the process is not clear; although it appeared that something in the culture free 
supernatant regulated by LuxS was contributing to the adhesion and biofilms 
formation. Ectopic expression of uvrY led to ruthenium red stainable nuclei in the 
biofilms, indicating that EPS, among other factors, contributed to enhanced biofilms 
formation.  However, over expression of luxS did not exhibit similar intense 
ruthenium red-stainable nuclei, although there was considerable EPS production as 
seen under a microscope.  Interestingly, the average depths of the films were over 40 
µm in either case (not shown).   
 
Regulation of genes involved in attachment 
Attachment and biofilms formation in a fim background indicated factors other than 
type 1 fimbriae as initiating biofilms. Apart from EPS, type 1 fimbriae and antigen 43 
have been implicated in initial attachment and biofilms formation [207-210].  Neither 
did ectopic expression of luxS did not exhibit EPS producing nucleated bacterial 
clusters.  Since global gene expression in E. coli biofilms is known [208], the 
expression of  flu encoding (Ag 43) assisting biofilms formation, was determined in 
various background.  Using quantitative RT-PCR on total RNA isolated from various 
cultures, the level of flu mRNA was down regulated in both barA and uvrY mutants.  
The level was 26% less than wild type in the barA mutant and 34% less (more than 2 





Confocal Image Analysis   
Mutation in uvrY reduces thickness of biofilms significantly. The thickness of the 
biofilms in the wild type and uvrY complemented strains were approximately 60 µm 
in depth whereas that in an uvrY mutant cells are almost as in a monolayer as average 
E. coli length is 2-3 µm (Figure 17).  As a control, uvrY also restores biofilm 
formation in a fim strain suggesting that fim independent pathways also controlled 
by uvrY. Loss of uvrY was also marked with poor microcolony formation and reduced 
thickness.   Scanning electron micrographs of mutants indicated that a deletion of 
either barA or uvrY led to a decreased visible cell surface appendages and 
extracellular coatings traditionally seen on a E. coli saturated culture or taken from 
solid surfaces (not shown).  The surface architecture of the mutant bacteria indicated 
that the adhesion defect may be due to a defect in the pili and surface adhesins.   
 
Effect of uvrY on swarming motility 
One commonly surface associated behavior controlled in a population dependent 
manner is Swarming Motility, a process of flagellar dependent locomotion.    In E. 
coli K-12, flagellum is critical for initial attachment and overcoming repulsion 
between similarly charged bacterial and inert surfaces [211]. In E. coli K-12, the 
transcription of flagella genes and exopolysaccharides are oppositely regulated.  It is 
thought that flagella plays a role in motility and when bacteria become associate with 
a surface, flagella genes are shut off while exopolysaccharide synthesis were up 
regulated.  Mutation of uvrY impairs the ability to swarm on a semi-solid agar plates 
in presence of glucose (Figure 18). The swarming ability is restored upon 




expression of both flhD and flhC, the expression of both could be increased upon 
complementation.  
 
Mutation of uvrY exhibits poor colonization in ascending model of UTI 
The ability of uvrY mutants were also tested in an ascending mouse model of UTI. 
Lack of uvrY displayed a reduced ability to colonize either in kidneys or bladder 
(Figure 19). The ability to persist in urine is also significantly impaired.   
 
Discussion 
Biofilm formation requires a modulation of gene expression facilitating initiation, 
attachment and subsequent maturation.  In E. coli, biofilm development is governed 
by several factors including Type 1 pilus and flagellar motility.  The initial process of 
attachment is mediated by several adhesins of which Type 1 and Pap Pili play a 
critical role in colonization in Urinary bladder and Kidneys respectively.  We tested 
the involvement of a model two-component regulatory system, the BarA-UvrY TCS 
in Uropathogenic E. coli in an ascending model of Urinary Tract Infections.  The 
ability to cause urinary tract infections by UPEC relies on its ability to form 
intrabacterial biofilms in the bladder, in the form of pods in a polysaccharide based 
matrix.  Such intrabacterial communities (IBC) have been demonstrated to express 
type 1 pilus, Ag43 and polysaccharides.  We have seen uvrY mutants do not persist 
very well in bladder or kidneys as compared to the corresponding wild type.   
Hence a mutation in uvrY might affect persistence in bladder/kidney in several 




adhesion in bladder and kidney respectively and the ability to form biofilms in these 
organs.  Specifically, bladder mucosal cells express Tamm Horsefall protein, which 
interacts with Type 1 pilus and other adhesins of UPEC for internalization.  A 
mutation in uvrY predisposes the fim switch to OFF phase further indicate that 
afimbriated bacteria are not able to colonize the bladder as well as the fimbriated wild 
type.  
Initial stages of biofilms for successful colonization in the bladder could thus be 
prevented.  Secondly, a mutation in uvrY in UPEC would result in hypersensitivity to 
hydrogen peroxide.  Even biofilms that are formed by an uvrY mutant might be 
subsequently cleared due to the oxidative burst by the PMN and subsequent 
phagocytosis. Wild type biofilms (IBC) in contrast would be difficult to penetrate due 
to polysaccharide based matrix and protective uroplakin.  Thirdly, Quorum Sensing 
might be inhibited which would block cooperation, coordination and appropriate gene 
expression among members of the biofilm community (unpublished results).  This 
would result in alteration of biofilm phenotype, if not a weaker biofilm. Interestingly, 
biofilms formed by QS mutant display a greater sensitivity to hydrogen peroxide in 
Pseudomonas spp.  Finally, flagellar motility might also play a key role in ascending 
model of UTI, even though flagellar motility may not be absolutely critical for 
virulence. In fact, studies have shown down regulation of flagella in UPEC during 
infection, most likely to avoid triggering of TLR-5 type mediated innate immune 
responses resulting in IL-8 production.  However, transient expression of flagellar 
motility is thought to be important for initial colonization of UPEC in urinary tract. 




demonstrated that flagellar motility is important for colonization against a strain 
which lacks such traits and thereby contribute to fitness of UPEC.  Thus, mutation in 
uvrY might affect stages in colonization/intracellular biofilm formation 
(IBC)/fitness/persistence of UPEC in the urinary tract.  
On the other hand, Hospital acquired UTI are widespread due to the ability of bacteria 
to adhere and form biofilms on the abiotic surface of  indwelling medical devices 
such as catheters, renal dialysis shunts and prosthetic valves. A significant proportion 
of UTI (more than 90%) under clinical settings is catheter related and designated as 
“Catheter-Associated Urinary Tract Infection” (CAUTI).  CAUTI have been reported 
to increase mortality and correlated with increased mortality in immunocompromised, 
debilitated and diabetic patients. With that in mind, in vitro test for biofilm formation 





Figures and Tables 
 
Figure 13.  Effect of mutation of uvrY in biofilm formation on abiotic surfaces.  
Figures A and B represent biofilm formation as detected by crystal violet staining 
after 24 hours in glass and PVC microtiter plates respectively.  Figure C shows 










































































Figure 14. Mutation in uvrY reduced expression of fimA and papA, major fimbrial 
subunit of type 1 and pap pilus respectively.   Semi-quantitative RT-PCR exhibiting 
reduced expression of fimA and papA upon loss of uvrY.  The expression could be 



















Figure 15.  Mutation of uvrY affects fimbrial switch orientation and expression. 
A. Inverse PCR to determine orientation of the “fim switch”. Two independent 
genomic DNA isolates from each strain is used for amplification reaction for 
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B. RT-PCR of the recombinase fimB, fimE and ipuA demonstrating that while the 
expressions of fimB and fimE recombinases were downregulated ipuA doesn’t have 



















C.  CsrA stabilizes fimA transcript.  Mutation in csrA decreases fimA mRNA half life 
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Figure 16.  Mutation of uvrY reduces acidic exopolysaccharide accumulation. The 











Figure 17.  Confocal images exhibit reduced biofilm thickness in uvrY mutant.  
Mutation of uvrY leads to a significant reduction in biofilm thickness which could be 











(4.0 ± 1.5 µm)
ΔuvrY/p-uvrY
(75.0 ± 2.5 µm)
 
 
Figure 18.   Effect of mutation of uvrY on swarming motility. 
A. Impairment of swarming motility upon loss of uvrY in CFT073.  Swarming 



















B.  Semi-quantitative and real time RT-PCR demonstrating reduction in flhD 
expression upon mutation of uvrY in CFT073.  flhC also displayed a similar change in 
gene expression (not shown) 
 
 









































Figure 19.   Mutation of uvrY reduces colonization in an ascending model of UTI. 
Mutation in uvrY displays poor colonization in an ascending model of Urinary Tract 
Infection.  The open symbol represents the wild type whereas the filled symbols 
































































Table 3.  Mutation in the BarA/UvrY TCS in APEC strain χ7122 leads to lower pilus 
expression, exopolysaccharide production, and increased susceptibility to oxidative 
stress.  For real-time RT-PCR, Threshold cycle (CT) values were determined for 
various amplification products. The ΔCT values between samples were normalized to 
those for the rrnA product, ΔCT = (CT of mutant _ CT of rrnA) _ (CT of wild type _ CT 
of rrnA) and fold difference in the initial concentration of each transcript is 
determined as 2-ΔΔCT. The values are the means with standard deviations of the mean 
for two independent experiments in triplicates. The wild type was assigned a value of 
1.0. The downward arrow indicates down regulation compared to the wild type.   
The hydrogen peroxide sensitivity was measured by putting a sterile filter paper disc 
soaked with 1% hydrogen peroxide on top of freshly overlaid bacteria (5 log10 CFU 
bacteria) in soft agar. The results are mean diameters of inhibition after 18 h of 
incubation at 37°C with standard deviations of the means. 
For EPS determination, bacteria were grown on LB agar overnight at 37°C, harvested 
by scraping, and resuspended in 2.5 ml of PBS. The cell number was determined 
from the turbidity at 600 nm.  EPS was separated from the bacteria by vortexing each 
sample for 10 min, followed by ultracentrifugation of the bacterial suspension at 
160,000 g for 60 min at 4°C. The supernatant was removed and dialyzed in double-
distilled water for 3 h in a membrane with a 6-kDa cutoff. Uronic acids are common 
constituents of bacterial EPS.  Uronic acid produced by various bacterial strains was 
determined by a colorimetric method, using pure uronic acid as a standard, and 








Table 4.   Mutation in barA and uvrY exhibits a reduction in mannose resistant  
hemagglutination to chicken erythrocytes. The values are mean log2 of inverse 
dilution at which hemagglutination (HA) was observed with chicken blood. The 
standard deviation was <0.05 in all cases.  The bacterial cultures were grown with 
two passages of 48 h each in static LB broth with appropriate antibiotics at 37oC to 
maximize type 1 fimbria expression.  The assay was done on ice in duplicate in 96-
well microtiter plates. Each bacterial culture was diluted twofold, before blood was 
added to study agglutination. The experiment was repeated twice with essentially 
similar results. The highest reciprocal of the dilution at which 50% of the erythrocytes 
sedimented to the bottom of the plate is taken as the HA titer. 
 
 Hemagglutination of 1% 
chicken  erythrocyte  
log 2 [1/dilution] 
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Chapter V:  Escherichia coli stress response as a tool for 
detection of toxicity 
 
Introduction 
The advent of microarray has opened new avenues for toxicologists to collect and 
interpret data [212-215].  It usually involves a comparison of global gene expression 
between normal and drug treated cells under in vitro conditions. The incorporation of 
genomics, bioinformatics and large-scale sequencing information have resulted in the 
construction of gene chips, which enable speedy screening of new targets for 
important cellular processes including toxicity.  The emerging branch of 
toxicogenomics integrates application of functional genomics technologies and offers 
several advantages to that of conventional toxicology in terms of cost and time 
effectiveness, sensitivity and enhanced correlation between experimental models and 
human. Potential applications of this discipline are mechanistic insight of metabolic 
or biological pathways leading to toxicity, specially metabolic processes  (at the level 
of transcription) affected by chemical, environmental or xenobiotic treatments, 
screening of probable drug candidates, facilitating the prediction of toxicity of 
unknown compounds, and improving interspecies and in vitro-in vivo extrapolations 
[216, 217].  
 
The evolution of toxicogenomics has matured over the years with several series of 
developments in toxicological sciences. Previously, animal toxicity was assessed by 




mortality. However, animal bioassay was often lengthy, labor-intensive, expensive 
and limited in information [218-220].  Screening of more than fifty-thousand known 
chemicals for toxicity would be unfeasible using conventional methods; hence, newer 
alternative strategies are needed.  
 
In recent times, the focus has shifted towards understanding toxicity at the molecular 
level.  In the last thirty years, evaluation of toxicity underwent a remarkable 
transformation from assessing a single molecule change to the effect on entire 
genome.  Genomic information plays a key role in understanding of the molecular 
attributes of toxicity, for example, the genetic background of an individual could 
influence metabolism, absorption, excretion or susceptibility of a metabolite or a 
chemical entity.  The integration of genomics into the field of toxicological research 
will significantly advance our knowledge of molecular toxicity and key regulatory 
pathways that affect such processes (Fig. 1). Potential usefulness of genomics could 
be immensely important and often involves approaches that utilize candidate targets 
which are affected by environmental stimulants. Conversely, meticulous approach 
must be followed while analyzing genomic data and experimentation for validation 
must be integrated within such studies [221, 222].  
 
Escherichia coli, a type bacterial type species of the family Enterobacteriaceae, is 
naturally distributed in the intestinal microbial flora of homeothermic animals 
including birds and humans [223]. Strains of E. coli are broadly categorized in three 
groups: commensals, intestinal pathogenic and extraintestinal pathogenic. The 




been formed based on the presence of specific virulence factors and the ability to 
cause organ infection outside the intestine [18, 26, 27]. Typically, ExPEC 
characteristic virulence factors aid in invasion and colonization of the microbe which 
lead to infection in extraintestinal sites. Some ExPEC-specific virulence factors 
include adhesins (e.g., Type 1 fimbriae or P fimbriae), factors that evade defense 
mechanisms (e.g., capsules, lipopolysaccharides), toxins (e.g., hemolysins), and 
factors to acquire nutrient availability (e.g., siderophores) [28].  
 
ExPECs are a growing concern, as evidenced by being causative agents of a plethora 
of diseases, including urinary tract infections (UTI), neonatal meningitis, pneumonia, 
septicemia, osteomyelitis and other extraintestinal infections [224-226]. Among the 
ExPEC, uropathogenic E. coli (UPEC) and avian pathogenic E. coli (APEC) cause 
significant morbidity and/or mortality in humans and poultry respectively.  UPEC is 
the leading cause of urinary tract infections in the United States.  Every year in the 
United States, UPEC associated-UTI results in 6-8 billion cases of uncomplicated 
cystitis with a healthcare cost of $1 billion, 250,000 cases of uncomplicated 
pyelonephritis with a direct cost of  $175 million, and 250,000 to 525,000 cases of 
catheter-associated UTI healthcare, the cost of which is $170-350 million dollars 
[30]. APEC, on the other hand, is the leading cause of avian colibacillosis 
characterized by air sacculitis, pericarditis, peritonitis, salpingitis, polyserositis, 
septicemia, synovitis, osteomyelitis and yolk sac infection [227, 228].  In the US, 
cellulitis caused by APEC is the second leading cause of condemnation of broiler 




mechanisms of pathogenesis and toxicity of Escherichia coli have become more 
apparent with the application of genomics, bioinformatics and molecular biology.   
 
Unlike commensals, many pathogenic bacteria were demonstrated to switch between 
free-living and host-associated states.  Apart from extraintestinal sites, EXPECs have 
been reported to asymptotically colonize in intestinal sites like commensals [226, 
230].  In contrast, the intestinal pathogenic strains are not capable of asymptomatic 
colonization in the intestine.  The environments in which EXPECs thrive vary and 
must endure different stress conditions within the host.  Often, the pathogenic bacteria 
have developed a complex signaling system that turns on specific sets of genes in a 
given environment and switch off those that are not required in that milieu. Multiple 
physiochemical cues, such as pH, osmolarity, temperature, and oxygen concentration 
might affect such change in gene expression.  Interestingly, the gene expression 
pattern might be altered due to the presence of different environmental stimuli 
including those of various toxic chemicals. Regulatory mechanisms which affect such 
changes are complex and take place at the levels of transcription and translation.  The 
overall effect of such changes in genome might be envisioned by the incorporation of 
genomics into this emerging field of toxicology.  
 
Stress Response 
The effect of various stress responses on E. coli has been studied in greater details 
[231-237]. Molecular oxygen, for example, plays a crucial role in cellular 




superoxide radical, hydrogen peroxide and hydroxyl radical can be deleterious and 
may even cause apoptosis of the aerobic cells. Various strategies, including 
enzymatic and non enzymatic defenses have been employed to prevent such damages 
[238]. Enzymatic defense systems, such as superoxide dismutase, catalase and 
peroxidase, scavenge superoxide radicals and hydrogen peroxide and convert them 
into less reactive species. Non-enzymatic antioxidants include Vitamin C and E, 
glutathione and β-carotene. Usually a balance exists between ROS and antioxidants 
under normal conditions of the cell. A disruption in this critical balance could lead to 
oxidative stress either due to excess accumulation of ROS or depletion of antioxidants 
[239]. These, in turn, either damage cell components or trigger specific cell signaling 
pathways leading to modulation of various cellular processes, improving the health of 
the cell or leading to cell death [240].  
 
Release of ROS changes the oxidation reduction potential within the cell, leading to 
oxidative stress. The generated ROS molecules can carry out nucleophilic attacks on 
any electron-deficient group including biomolecules such as DNA, protein and lipids 
leading to the formation of adduct, covalent binding of ROS to macromolecule and 
disruption of cellular functions. The basic mechanisms to remove ROS involve 
chemical reactions that generate a non-reactive compound by altering gene expression 
to activate gene products that are designated to deal with toxic insults and turn off 
those that are not required.  Cellular oxidative stresses are controlled either by direct 
or indirect alteration of gene expression. Chemicals or ROS may activate intracellular 




interact with other molecules within the cell, which carries on the signal and elicits 
coordinated responses to cellular toxicity.  
                           
Bacteria have developed adaptive responses while shifting from anaerobic to aerobic 
growth conditions to counteract reactive oxygen species [241]. Usually, these 
responses are mediated in a coordinated manner by groups of genes termed regulons, 
each group under a common regulator. One key system is based on the oxyR system 
which acts in response to hydrogen peroxide and induces at least eight genes to 
counteract oxidative stress, including ahpFC encoding alkyl hydroperoxidase, 
glutathione reducatase encoded by gor, katG encoding catalase hydroperoxidase and 
dps, a DNA binding protective protein.  OxyR protein is thought to act by binding 
and stimulating transcription from various promoters upon receiving signals. Many of 
the OxyR regulon genes are also regulated by the stationery phase starvation response 
system programmed by rpoS, a sigma 38 protein. The stationery phase alternative 
sigma factor rpoS controls the expression of several genes involved in cell survival 
and is essential for expression of various stress resistances [175, 242, 243]. Under 
laboratory conditions, rpoS mutants are sensitive to oxidative and osmotic stress as 
well as temperature and acid shift. On the other hand, the SoxRS system induces 
many genes to combat the superoxide-generating agents and nitric oxide. The SoxRS 
response is initiated in two stages. Upon activation, the soxR sensor molecule induces 
soxS which, in turn, activates the transcription of soxRS regulon. The stationery phase 
alternative sigma factor σS is present in many bacterial species belonging to γ 




the level of transcription, post transcription and protein stability [244]. In E. coli 
rpoS transcription is regulated by cAMP-CRP complex as well as by several two-
component signaling systems, including the BarA/UvrY system whose role is 
illustrated [173, 245-247]. 
 
Genomics are increasingly more useful in exploring pathways and mechanisms 
underlying oxidative stress response. DNA microarrays have been used to 
characterize genes involved in oxidative stress responses. Interestingly, the patterns of 
gene expression altered in mammary cells in the presence of hydrogen peroxide, 
menedions, and t-butyl hydroperoxide were found to be quite similar regardless of the 
ROS source [248].  Another study showed that the effect of DMNQ, 2, 3-dimethoxy-
1,4-naphthoquinone, a ROS-generating chemical,  in HepG2 cells was comparable to 
that of heavy metal toxicity [249]. Such studies have substantiated the notion that 
different stimuli can lead to generation of ROS and oxidative stress (Fig. 2.). Hence, 
production of ROS and oxidative stress might be considered as a general stress 
response. 
 
Two-component as signal transducers 
Wide range of toxic insults often alters gene expression profiles in microbes specific 
to the nature of chemicals tested.  Adaptation to toxic compounds by bacterial species 
often enables that species to better cope in that environment.   This response, 
appropriately called adaptive response, refers to the ability of bacteria to withstand 




the similar stress environment at a lower dose. Several types of agents induce an 
adaptive response, including alkylating agents, heat stress, oxidative stress and 
radiation among others.  Adaptive response usually involves modulation of a plethora 
of genes in a coordinated manner.  In bacteria, adaptation to a new environment 
largely relies on a signal transduction system called the two-component system.  
There is no common pathway for adaptation; however there exists quite a few 
common themes.  In E. coli adaptation to a new environment often involves use of 
several two-component systems that plays a crucial role for survival in an ever-
changing environment. Two-component systems (TCS), comprises of a membrane-
bound sensor histidine kinase (HPK) and a cognate response regulator (RR).  The 
sensor kinase undergoes autophosphorylation at a conserved histidine residue upon 
reception of an appropriate environmental signal, and subsequently, this phosphate 
group is transferred to a conserved aspartate residue on the cognate response 
regulator. Upon phosphorylation, the response regulatory protein undergoes structural 
modification and acts as a gene transcription factor and often regulates gene 
expression or cellular responses, enabling the organism better adapt in new 
environment [1, 2, 250].  Approximately 60 such TCS are present in E. coli and have 
been shown to be involved in adaptation, including intracellular metabolism, biofilm 
formation, global stress response and virulence. One such system is the BarA-UvrY 
TCS involved in various physiological functions including oxidative stress, sigmaS 





The BarA (Bacterial Adaptive Response Gene A) sensor kinase was first identified 
for its ability to suppress a deletion envZ mutant by controlling expression of outer 
membrane proteins [166, 251]. BarA is a member of tripartite sensor kinase having 
three domains: an N-terminal transmitter domain with a conserved histidine residue 
(H1), a central receiver domain with a conserved aspartate residue (D1) and a C-
terminal transmitter domain with a conserved histidine residue H2, also called Hpt 
domain. Triggering of this system seems to be mediated in an ATP- dependent 
manner via His-Asp-His-Asp phosphorelay cascade. UvrY is a member of the FixJ 
family and has been recently shown to be a cognate regulator of the sensor kinase, 
BarA [176]. It has an N terminal phosphoacceptor domain with a conserved aspartic 
acid residue at position 54, followed by a LuxR type helix-turn-helix DNA binding 
domain in the C-terminal region. It also has a close linkage with uvrC, a bicistronic 
mRNA, even though uvrY has no known role in DNA repair system.  Apparently this 
system seems to be induced in response to a pH change. 
 
The BarA/UvrY system plays a crucial role in carbon metabolism and biofilm 
formation.  This TCS has also been implicated in hydrogen peroxide resistance. Both 
the barA and uvrY mutants were hypersensitive to hydrogen peroxide.  It has been 
reported that the expression of the sensor kinase, barA, could be induced in the 
presence of weak acids, possibly indicating the significance of this TCS in survival of 
acid onslaught in stomach and inside macrophages. Additionally, this TCS could be 
induced in the presence of food preservatives such as benzoate or bile salts, implying 





Bacterial Biosensors as a tool for detection of toxicity 
Presence of environmental stimulants or toxic chemicals often elicits variety of stress 
responses in bacteria. Compounds demonstrating similar toxicities would ideally 
induce a specific pattern in gene expression. It is hypothesized that compounds that 
exhibit similar changes in gene expression might have similar mechanisms of action 
or act in similar biological processes or pathways.  Thus, toxicity-induced alteration 
of gene expression might be used as a signature for classification and characterization 
of unknown chemicals. Genomic insults due to toxin-induced stimulation induce 
several stress responses, with alteration in gene expression that are often associated 
with diverse biological pathways. Once within the host, pathogenic bacteria often 
deal with diverse stress responses such as pH, nutrient deprivation, high osmolarity 
and oxidative stress.  Inflammatory cells or phagocytes possess enzymes that are 
capable of generating ROS in response to invasion of pathogens. However, excess 
production of ROS also might affect the phagocytes and the surrounding tissue. 
Chronic renal scarring in pyelonephritis has been directly correlated with phagocytic 
oxidative damage.  Hence, virulence genes involved in colonization or survival inside 
the host often have common genes that are affected by stress responses.  Such genes 
have often been used as a sensor for detection and quantization of toxic chemicals in 
the environment. These sensors have the potential to be a warning system for toxicity 
detection and thereby reduce harmful effect on the environment.   
 
Whole-cell bacterial biosensors detect gene products of reporter genes that are either 




Commonly used reporter genes include lacZ encoding β-galactosidase (E. coli), lux 
encoding bacterial luciferase, luc encoding firefly luciferase and gfp encoding green 
fluorescent protein.  In the case of general biosensors, the reporter gene is placed 
downstream to a constitutively expressed promoter, and a decrease in intensity of 
signal indicates a decrease in metabolic activity.  On the other hand, semi-specific 
biosensors involve placing a reporter gene downstream to a stress-responsive 
promoter and an increase in reporter activity indicates an increase in stress (e.g., SOS 
or heat shock response). Furthermore, specific biosensors incorporate a reporter gene 
being placed downstream to a regulated promoter or regulatory protein, either 
activator or repressor. Even though general biosensors are most popular due to their 
simplicity, they are non-specific and could lead to false-positives. In contrast, stress 
responsive biosensors offer several advantages over that of general biosensors. As 
different stimulants often lead to common stress response, such sensors can be good 
indicators of toxicity and stress inducing conditions such as DNA and protein 
damage, oxidative stress and membrane damage. Their simplicity, selectivity and 
sensitivity have made them extremely useful and popular.  Specificity of such sensors 
might be increased by incorporating several different types of semi-specific 
biosensors to determine type and variety of toxicity. The stress promoter-reporter 
could be present in separate strains, or two reporters could be incorporated in the 
same strain. Identification of such stress-related genes for such sensors involves 
scanning through the transcription profile of the genome. Numerous stress gene 
promoter including sulA, katG, recA and uvrA, have been fused with a reporter to 




Panels of stress-responsive biosensors are also on the rise. Oxidative stress sensitive 
cell array chip have been employed for identification of putative targets in the entire 
genome [254].  Sensitivity of such sensors could be significantly improved by fine-
tuning the promoter and modification of host strains. Challenges for improvement of 
such sensors would encompass identification of strong promoters that are sensitive to 
a given stimuli, knowledge of gene regulatory network, designing of instruments that 
are easy to use and inexpensive, refinement of older reporters and creation of new 
reporter genes [255-258].  
 
 
Global gene expression profiling of the BarA/UvrY TCS 
To further identify downstream targets and pathways that are affected by the 
BarA/UvrY two-component system, we have begin to study the effect of mutation of 
either barA or uvrY and compare it with a wild-type or a mutant expressing the UvrY 
protein from a low copy plasmid-borne vector p-uvrY in UPEC CFT073.  At first, the 
raw digitalized intensity of Affymetrix single-color slides was internally normalized 
using Microarray Suite version 5 (MAS 5.0, Affymetrix). The universally ‘absent’ 
genes from the normalized data were then eliminated. The noise generated due to 
chip-chip non-biological variance was minimized through interchip-LOWESS 
normalization between the wild-type and individually treated samples using 
GeneSpring v6 (Agilent, Inc., CA). The resultant genomic regulation was determined 
as the ratio of the individual gene intensity of treated samples to that of the control 
samples. The normalized genes of the treated ensemble showing at least 1.15 fold 




remaining analysis. Approximately 1400 genes from the selected genome showed a 
similar regulatory trend between uvrY and barA strain, of which around 570 genes 
were from CFT segment and about 200 genes were from intergenic region. Similar 
analysis identified roughly 900 genes, including ~270 and ~100 entries from CFT and 
intergenic segment respectively that are expressed oppositely between uvrY and p-
uvrY strains. Apparently, about 170 regulated genes according to the aforesaid null 
hypothesis showed similar regulation between barA and uvrY strain while 
simultaneously exhibited reverse regulation between uvrY and p-uvrY strain. This last 
genome contained ~50 CFT genes and ~20 intergenic entries.   Unsupervised 
heretical clustering was performed for each of the three genomes independently using 
a standard correlation algorithm. To conclude, the biological, molecular and cellular 
functions of each gene, part of the abovementioned three genomes, were mined using 
NetAffix GeneOntology (GO) analysis tool (Affymetrix, Inc., CA), and the genome 
was segmented according to their primary functions.   
 
Several groups of genes have been annotated based on their function.  Genes involved 
in metabolism, biosynthesis, cell adhesion, transcription and translation, catalysis, 
membrane and many genes of unknown functions were significantly affected by the 
mutation. Representative genes that are affected at least two-fold by the mutation 
were reported (Table 1). This TCS, by virtue of its role in virulence, stress response, 
carbon regulation, and other key regulatory pathways in E. coli, could be a potential 






Toxicogenomics now evolves into a multi-disciplinary field by integrating several 
branches of biology including toxicology, genetics, molecular biology, 
bioinformatics, functional genomics, transcript profiling, proteomics, metabolomics 
and pharmacogenomics. With ongoing whole genome sequencing efforts, the 
potential for identifying candidates for toxicity testing or pathways has been 
significantly accelerated using available high throughput and inexpensive molecular 
genetic tools.  An important strategy towards identification of novel toxic chemicals 
involves employing potential targets that are susceptible to various stresses in the 
presence of deleterious compounds. Genomics enable pinpointing such potential 
candidates by scanning through an entire genome in a high throughput fashion. 
Identification, validation and categorical classification of such targets will enhance 
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 Figure 20.  Principle of evaluation of toxicity in toxicogenomics. 
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Table 5.  Microarray analysis of BarA/UvrY TCS in Uropathogenic Escherichia coli. 
 
 Gene Category or  Fold Description 
Name or ID Function Induction 
 
rfaJ  Biosynthesis 2.2 Lipopolysaacharide 1, 2-glycosyltransferase 
serB    2.1 Phosphoserine phosphotase 
hemA    2.2 Glutamyl tRNA reducatse 
hisB    2.5 Histidine biosynthesis bifunctional protein  
aroC    2.4 Chorismate synthase 
 
dsdA  Metabolism 2.3 D-serine dehydratase 
bglA    2.5 6-phospho-beta-glucosidase 
ldcC    2.6 Lysine decarboxylase 
c5039    2.4 Putative lactate dehydrogenase 
ucpA    2.2 Oxidoreductase 
 
kpsT  Transport  2.4 ATP binding transporter 
kpsM    2.1 ATP binding  
sitC    2.5 ABC transporters  
iroN    2.4 Siderophore receptor  
papC    2.5 Fimbrial usher protein 
malK    2.2 Maltose transporter 
 
focG  Adhesion  2.5 F1C minor fimbrial subunit protein  
c4209    2.3 Putative minor fimbrial subunit precursor 
c4214      2.7 Putative major fimbrial subunit precursor 
csgA    2.1 Major curli subunit precursor 
papH    2.5 Fimbrial protein 
 
papI  Transcription 2.2 Fimbrial protein transcriptional regulators 
flhC    2.6 Flagellar transcriptional activator 
ymfL    2.4 Hypothetical protein 
c2411    2.1 DNA-binding protein H-NS 
pcnB    2.2 Poly (A) Polymerase  
yhiH    2.3 Hypothetical ABC transporter 
 
fimB  Binding  2.7 Type 1 fimbriae regulatory protein  
zntA    2.4 Lead, Cadmium, Zinc transporting ATPase 
dppD    3.1 Dipeptide  transport ATP binding protein 
rseB    2.4 Sigma E factor regulatory protein 
c0934    2.7 Hypothetical Protein 
 
dsdA  Catalysis  2.3 D-serine dehydrates  
nrdD    2.1 Anerobic ribonucleoside triphosphate reductase 
trpB    2.5 Trytophan synthase beta chain  
agp    2.4 Glucose 1-phosphatase precursor 
ydjQ    2.7 Hypothetical protein 
 
mtr  Membrane  2.4 Tryptophan specific transport protein 
ompC    3.1 Outer membrane protein C precursor 
ompA    2.4 Outer membrane protein A precursor 
pitB     2.3 Probable low affinity inorganic phosphate transfer 
 
yjaN   Unknown  2.6 Hypothetical Protein 
yfgJ    2.4 Hypothetical Protein 





Chapter VI:  Conclusions and Future Directions 
The BarA/UvrY/Csr system and its homologues are present in many γ-division of 
proteobacteria.   The BarA/UvrY/Csr system regulates diverse physiological 
processes in adaptation of Escherichia coli.  This work demonstrates two population-
dependent physiological processes affected by this signaling cascade, namely a 
process of cell-cell communication termed quorum sensing which employs small 
molecules called autoinducers and the cooperative ability of bacterial species to form 
biofilms.  The study here demonstrates the role of BarA-UvrY TCS in regulation of 
adhesion mediated biofilm formation and cell-cell communication formation in 
Escherichia coli.  The fine control of processes affecting Quorum sensing, Biofilm 
formation and Stress responses all of which require careful coordination and 
environmental adaptation serves as an important strategy for survival of bacteria in a 
varying milieu.  The regulation of such processes at the level of transcription and post 
transcription by the signaling cascade suggest tighter control and coordination needed 
for efficient bacterial adaptation in a changing environment.  
Quorum sensing regulates diverse physiological processes like biofilm formation, 
antibiotic production, and virulence in many gram negative bacterial species.  
Quorum sensing involves population dependent control of gene expression by the 
utilization of autoinducers.   In E. coli, the autoinducer AI-2 is synthesized as a by 
product of methyl-cycle.  The specific reaction involves LuxS, which breaks down S-
ribosyl homocysteine to homocysteine, while generating the DPD. DPD undergoes 




and is thought to be involved in inter-species quorum sensing.    Mutation in barA or 
uvrY displayed reduced expression of luxS and AI-2 levels while mutation in csrA 
displayed an opposite effect, both at the entry into stationery phase. Transcript 
stability, computational prediction of luxS leader region, and direct regulatory 
interactions suggest that CsrA play a major role in regulation of luxS.   CsrA most 
likely bind to the predicted GGA- conserved stem loop region of luxS leader and 
inhibits translation initiation.  The known AI-2 uptake system, Lsr transporter, also 
displayed an interesting observation in E. coli.  While a loss of barA or uvrY genes 
displayed an increase in expression of Lsr transporter, loss of csrA on the other hand 
displayed an opposite effect.  This suggests a potential balance of carbon flow, as AI-
2 is a 5-carbon moiety, at the entry of sationery phase indicating that CsrA while 
repressing luxS expression it’s reducing the synthesis of AI-2, while utilizing the 
furanone (AI-2) by upregulating the lsr transporter.  Thus saving on energy utilization 
for synthesis of carbon at the onset of stationery phase seems to be the basis for 
regulation of luxS by the BarA/UvrY/Csr system. The involvement of small RNA in 
this regulation is also likely.  Interestingly, CsrA alongwith three small RNA also 
regulate Quorum sensing in Vibrio cholerae.  
Earlier studies have shown that mutation in barA or uvrY in Avian Pathogenic E. coli 
reduced expression of virulence in chicken embryo model and also demonstrate poor 
attachment in chicken fibroblasts and macrophages.  Downregulation of Type1 and 
Pap pilus and reduced exopolysaccharide accumulation was attributed for poor 
colonization and reduced virulence. In Uropathogenic Escherichia coli, the ability to 




towards persistent UTI.  In vivo, UPEC colonize bladder and kidneys by Type 1 and 
Pap pilus respectively.  The ability to form intrabacterial biofilm like pods also adds 
to the ability of the UPEC to persist in harsh conditions of the host.   The 
BarA/UvrY/Csr pathway also displayed a dual control at the level of transcription and 
post-transcription for biofilm formation in UPEC.  Both type 1 and pap pilus 
displayed reduced expression upon mutation of uvrY.  Both the recombinase fimB and 
fimE expression which controls the fim promoter switch was also downregulated.  
Additionally uvrY also displayed an ability to turn fim switch ON, but not csrA.   
This suggests that even though the BarA/UvrY TCS have a known downstream effect 
via CsrA, there also seems to be direct regulatory role in biofilm formation via 
regulation of pilus in UPEC.   Mutation of uvrY also displayed reduced 
exopolysaccharide accumulation and showed a swarm defective phenotype, both of 
which contribute to biofilm development.  Finally, uvrY mutants also demonstrated 
poor colonization in bladder, kidneys and urine in an ascending model UTI.  These 
suggest that uvrY might play a crucial role in adaptation, colonization and virulence in 
UPEC.    
 
Two-component regulatory systems have been utilized as a novel therapeutic strategy 
particularly those systems involved with virulence.  ExPECs cause significant 
economic loss in poultry and humans.  A vaccine towards ExPEC could help in 
reducing that financial burden.  This work demonstrates that phosphorelay signaling 
cascade through the BarA/UvrY two-component system is critical for adhesion, 




social behaviors in microbes, particularly for processes affecting adaptation, may be 
targeted for potential novel therapeutic strategies and this becomes relevant in recent 
years when antibiotic resistance is increasingly prevalent.  Targeting such pathways, 





Table 6.  List of bacterial strains and plasmids used in the study. 
 
     
Bacterial  




MG1655dlac    Wt K-12 λ- rph-1 Δlac          D. J. Jin   
 
SM1005    MG1655Δlac  luxS::lacZ                   Lab Stock 
  
SM1006    MG1655Δlac  luxS::lacZ barA::kan               Lab Stock 
 
SM1007    MG1655Δlac luxS::lacZ uvrY::cam               Lab Stock 
  
SM1009    MG1655Δlac  luxS::lacZ barA::kan uvrY::cam        Lab Stock 
 
SM1010                        MG1655Δlac luxS::lacZ rpoS::Tn10              Lab Stock 
 
SM1011                        MG1655Δlac  luxS::lacZ barA::kan/p-barA This study 
 
SM1012                        MG1655Δlac  luxS::lacZ uvrY::cam/p-uvrY This study 
 
SM1014                        MG1655Δlac  luxS::lacZ rpoS::Tn10/p-rpoS This study 
 
SM1020     MG1655Δlac  luxS::lacZ cya::kan   This study 
 
SM1021    MG1655Δlac  luxS::lacZ uvrY::cam cya::kan This study 
 
SM1030    MG1655Δlac  luxS::lacZ csrA::kan   This study 
 
SM1031                        MG1655Δlac luxS::lacZ csrA::kan/p-csrA  This study 
 
SM1032    MG1655Δlac  luxS::lacZ csrB::cam   This study 
 
SM1050    MG1655Δlac  luxS::lacZ hfq::cam   This study 
 
SM1051    MG1655Δlac luxS::lacZ hfq::cam/p-hfq  This study 
 





     
Bacterial  
Strains                           Relevant Genotype          Reference or source 
 
 
SM1053    TRMG1655 csrA::kan/p-hfq   This study 
 
SM1060     MG1655Δlac luxS::lacZ/p-sraD   This study 
 
SM1061     DH5α/ p-sraD                This study 
 
AM1001     MG166Δlac barA::kan         Lab Collection 
 
AM1002     MG166Δlac uvrY::cam         Lab Collection 
 
AM1003     MG166Δlac barA::kan uvrY::cam        Lab Collection 
 
AM1004     MG1655Δlac barA::kan/p-barA    This study 
 
AM1005     MG1655Δlac uvrY::cam/p-uvrY    This study 
 
AM1006     MG166Δlac luxS::cam         Lab Collection 
 
AM1007     MG166Δlac luxS::cam/p-luxS               This study  
 
AM1008     MG166Δlac luxS::cam/p-uvrY    This study 
 
AM1009     MG166Δlac uvrY::cam/p-luxS    This study 
 
RGB1655                       MG1655 csrB::cam                             T. Romeo
  
TR1-5 MG1655    MG1655 csrA::kan                             T. Romeo 
 
BB120      Wild type Vibrio harveyi  (AI-1+; AI-2+)         B.L. Bassler 
 
BB170      BB120 luxN::Tn5 (sensor-1- sensor-2+)          B.L. Bassler 
 
BB152      BB120 luxL::Tn5 (AI-1-; AI-2+)           B.L. Bassler 
 
JJ055      Nonpiliated K-12                       J. R. Johnson 
  
JJ014      Nonpiliated K-12/ p-fimA-H operon; Cmr          J. R. Johnson 
  





     
Bacterial  
Strains                        Relevant Genotype           Reference or source 
 
AAEC189                   K-12 Δfim Δlac                                          William R. Schwan 
 
χ7122     APEC O78:K80: H9 gyrA::Nal                         R. Curtiss (III)  r
SM3000  χ7122   barA::kan                Lab Stock 
SM3001  χ7122   uvrY::cam     Lab Stock 
 
SM3002  χ7122   barA::kan/p-barA               This study  
SM3004             χ7122   uvrY::cam/p-uvrY               This study 
 
SM3005  χ7122   luxS::cam                                                        Lab Stock 
 
SM3006  χ7122   luxS::cam/p-luxS       Lab Stock 
 
CFT073  Wt Uropathogenic E. coli            H. L. Mobley
  
SM3007  CFT073 luxS::cam                                                       Lab Stock 
 
SM3008  CFT073   luxS::cam/p-luxS       Lab Stock 
 
SM3009  CFT073 barA::cam                                                      Lab Stock 
 
SM3010  CFT073 uvrY::cam                   Lab Stock 
 
SM3011  CFT073 csrA::cam                            Lab Stock 
 
SM3012  CFT073 barA::cam/p-barA                                         Lab Stock 
 
SM3013  CFT073 uvrY::cam/ p-uvrY                Lab Stock 
 








    
 
Bacterial  
Plasmids      Relevant Genotype                      Reference or source 
pBR322        Cloning Vector                   Invitrogen 
 
pAN001        pBR322 containing barA gene; Apr                     Lab collection  
pAM001       pBR322 containing uvrY gene; Apr               This Study 
 
pCA114        csrA under ParaBAD control on pBAD18; Apr                       Craig Altier
  
pLuxS           PCR2.1 containing luxS gene;  Apr                    Lab Collection 
 
pFZY1          galK'-lacZYA transcriptional fusion vector; Apr                  W. E. Bentley 
 
pLW11         pFZY1 derivative, containing            W. E. Bentley 
          lsrACDBFG promoter region; Apr
      
 pPP2-6        pPR274 with MCS                 William R. Schwan
  
pBB2-1         fimA-lacZYA on pPR274             William R. Schwan
  
 pWS124-17 fimA-lacZYA locked on on pPP2-6            William R. Schwan
 
pJLE4-3        fimE-lacZYA on pPP2-6              William R. Schwan
 
 pJB5A         fimB-lacZYA on pPP2-6                          William R. Schwan
 








Table 7.  List of primers used in this study  
 
 
Primer  Sequence (5’-3’)                                     Gene/target sequence     
Designation   
 
 
OSM79    TGATCCTGCACTTTCAGCAC                                    luxS 
OSM80  CAATCACCGTGTTCGATCTG 
 
OSM250  AGCGTTCTGTAAGCCTGTGAAGGT                         rrnA 
OSM251  TAACGTTGGACAGGAACCCTTGGT 
 
OSM252  GGCACATTCTGGCAGCAAGTTGTA         lsrK 
OSM253  TTTCTTCGGCACAGAAAGCATCGC 
 
OSM254  TGCGCCCTTACTCATAACCTTCGT         lsrA 
OSM255  CAATACTTGCGGCGAAGCTTCCAA 
 
OSM256  AACCACAACAGATGCTGGCGATTG         lsrR 
OSM257  TTAAGCTGCCCGATTCCCGTCATA  
 
OSM258  ACTGTACATGGTACACGCACTGGAT         flu 
OSM259  TTCAGGGTGACATTCGTGGCTGTA 
  
OSM260  ACCGTTCAGTTAGGACAGGTTCGT        fimA 
OSM261  TCTGCAGAGCCAGAACGTTGGTAT 
 
OSM271  GGAATCGGTGTAGATGTAACCCC           icd  
OSM272  CGTCCTGACCATAAACCTGTGTGG 
 
OSM275  ATGCCGCAGGTATCCCGATG        manA 
OSM276  GCGCGGGATTTTTCTTCACC 
 
OSM277  AGCCCGTTCAATGCTGCCAG        manX 
OSM278  GTTGGAGCCGCTTTTGGTGC 
 
OSM279  TCGCACTGGCAATCCCTCTG       manY 
OSM280  CATCAGGTAGCCAGCACGCA 
 
OSM281  AGTTCGTCAGGGTCTGGCGA       galU 





Primer  Sequence (5’-3’)                                     Gene/target sequence     




OSM283  TTGTGGGGCGCAGAAAATGT        rcsD 
OSM284  CGACCGTTGCCAGATGTCCT 
 
OSM285 AACCTGCCGAAACTGGATGC        rcsB 
OSM286 AGCTTTCGGCAGATCGGTCG 
 
OSM287 GCTCGTCACGGTCGCAACAA        lrhA 
OSM288 ACATCCAGCGCTAATTTCGG 
 
OSM289 AACGGCAGAGGGCGATTTGT      wcam 
OSM290 AGCGTGGCTAACGGTCAGGT 
 
OSM291 CCATGATGCAGGCGGTTTGT       fimE 
OSM292 GCACGTTCCTGGGTCCACAT 
 
OSM293  CCGGTGGCGCTTTATTTGAC       fimH 
OSM294  AGAAACATCGCAGCCGCCAG 
 
OSM295  CAGTAATGCTGCTCGTTTTGCCG        fim promoter 
OSM296  GACAGAGCCGACAGAACAACG 
 
OSM297  CGACAGCAGAGCTGGTCGCTC       fim switch orientation 
OSM298        GTAAATTATTTCTCTTGTAAAT 
                                    TAATTTCACATCACCTCCGC 
OSM299  GCGGAGGTGATGTGAAATTAA 
                                    TTTACAATAGAAATAATTTAC 
 
OSM309  ACTCTGCGGACCACTTGGGA               papA 
OSM310  CCAACTATTCCTCAGGGGCA 
 
OSM311  AACTCAACGGCACTGGCTGC                              papH 
OSM312  CTCAGAATTGTGCGAAACGG 
 
OSM313  CAGCAACTCAGCACCAGGAC   glmU 
OSM314  CTTACTCACGGGCGCGATGT 
 
OSM315  GATGAAACCGCAGAAGGCTT   kpsE 







Primer  Sequence (5’-3’)                                     Gene/target sequence     
Designation   
 
 
OSM317  TAATACGACTCACTATAGGGA                         T7-luxS 
                                    GAGGCTGGAAAAACAC 
OSM318  CGCTTCCATCCGGGTATGATCG         
 
OSM345  TATTCCGAGCCATCAGGGTG              hlyC  
OSM346  TTCGTGCTTTGTCCTGCTGA 
 
OSM347  CAAGGGCGCTGGTGAACAAC   hlyB 
OSM348  AACAGGAACTCGCTGAACCC 
 
OSM349  CTTACTCACGGGCGCGATGT   glmU 
OSM350  CAGCAACTCAGCACCAGGAC 
 
OSM351  AGTTCGTCAGGGTCTGGCGA   galU 
OSM352  CAACGCCATATGCGGTCACA 
 
OSM353  GTACGGCGATGGCATTACCT   rcsB  
OSM354  ACCGTAACCACCAGCACTGA 
 
OSM355  ACGACCGTTGCCAGATGTCC   rcsD  
OSM356  TTGTGGGGCGCAGAAAATGT  
 
OSM357  CCATGATGCAGGCGGTTTGT   fimE 
OSM358  CCACGGCTTCACGCTCATCA 
 
OSM359  GCCAAAGCAAAACCACACGA   fimB 
OSM360  AACGCACCCGCTATTGAACA 
 
OSM361  TGCACGTTTTCCAGCCTCAC    ipbA 
OSM362  TGATGGCTTTCATTCACGGT 
 
OSM363  TTTCATGGTCTGCGTGTTAGTG   ipuA  
OSM364  TTACCCGCAGCAGAAACTATGT 
 
OSM365  CCCCTGCAAAAAGAAACTGT   ipuB 










APEC     Avian Pathogenic Escherichia coli 
AHL       N-acyl homoserine lactone 
AIP     Autoinducing Peptide 
AI-2        Autoinducer 2 
BarA      Bacterial Adaptive Response gene A 
Csr   Carbon Storage Regulator  
ExPEC    Extraintestinal Pathogenic Escherichia coli 
HPK        Histidine Protein Kinase 
HTH      Helix-turn-helix 
PBS       Phosphate Buffered Saline  
RT-PCR  Reverse Transcriptase Polymerase Chain Reaction 
RR           Response Regulator 
TCS         Two-component regulatory system 
UPEC      Uropathogenic Escherichia coli 
UTR      Untranslated Region 
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